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ABSTRACT 
The maternal mode of mitochondrial inheritance is conserved across mammalian 
species; however, little is known about how mitochondria from the sperm are eliminated 
from early mammalian embryos. Mitophagy, the regulated degradation of mitochondria in 
the lysosome, has been proposed as a possible mechanism. Mitophagy is an important 
means by which the cell responds to changes in mitochondrial fitness, and has been 
observed under a number of physiological and non-physiological circumstances, including, 
but not limited to, hypoxia, mitochondrial depolarization, mitochondrial fission, and 
erythrocyte differentiation.  
Here we examine the core component of mitophagy proteins involved in three 
physiological states: respiration-induced mitophagy in cultured mouse fibroblasts, 
mitophagy of dysfunctional mitochondria in the absence of mitochondrial fusion, and 
degradation of paternal mitochondria in pre-implantation mouse embryos. We find that a 
common pathway is used for elimination of mitochondria, involving mitochondrial 
depolarization, and the E3 ubiquitin ligases PARKIN and MUL1. We find that PARKIN 
and MUL1 play partially redundant roles in elimination of paternal mitochondria that is 
also dependent on PINK1 kinase, the fission factor, FIS1, and the autophagy receptor, p62. 
We find that p62 is specifically recruited to defective mitochondria in fusion deficient cells 
by a mechanism independent of ubiquitin binding. Our results elucidate the molecular 
mechanism of strict maternal transmission of mitochondria and uncover a collaboration 
between MUL1 and PARKIN in mitophagy.  
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C h a p t e r  1  
INTRODUCTION 
Mitochondrial Homeostasis 
Mitochondria are vital organelles that are essential for aerobic respiration. 
Originally independent prokaryotic cells, they were engulfed and co-opted by 
eukaryotic hosts for their ability to perform oxidative phosphorylation to produce 
ATP. This primordial history also points to another of the mitochondrion’s unique 
traits: its genome. Mitochondria are the only organelles that carry and maintain 
their own DNA, termed mtDNA. In mammals, mtDNA follows a maternal 
inheritance pattern that is distinct from that of the nuclear DNA. Furthermore, 
mitochondria are highly dynamic structures that exist as part of a network, which 
is constantly remodeling itself to maintain the function of the population as a 
whole. As highly active organelles, mitochondria can accumulate damage to 
proteins, lipids, and DNA.  
A variety of quality control mechanisms have been discovered to mitigate 
this damage. Mitochondria have their own proteolytic system which degrades 
misfolded proteins (Haynes and Ron, 2010), and they utilize the proteasome to 
degrade damaged outer mitochondrial membrane proteins (Taylor and Rutter, 
2011). Moreover mitochondria can degrade oxidized proteins via the recently 
discovered mitochondria-derived vesicles, which bud off damaged mitochondria 
and are degraded in the lysosome along with their contents (Sugiura et al., 2014). 
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In addition, damaged mitochondria can be segregated from healthy mitochondria 
by mitochondrial fission, and healthy mitochondria can combine their components 
by mitochondrial fusion (Chen et al., 2005; Twig et al., 2008). Finally, 
dysfunctional mitochondria that are sequestered by coordinated fission and fusion 
can be degraded by a specialized form of selective macroautophagy, called 
mitophagy. Mitophagy leads to degradation of mitochondria in the lysosome 
(Ashrafi and Schwarz, 2013), and has been suggested to be an important 
mechanism for protection against alcohol-induced liver injury (Williams et al., 
2015), neurodegenerative disease (Palikaras and Tavernarakis, 2012) cancer 
(Chourasia et al., 2015), and even aging (Richard et al., 2013). 
Here we present work investigating the players in three specialized forms 
of mitophagy: first, mitophagy induced by elevated respiration, which we refer to 
as OXPHOS-induced mitophagy; second, mitophagy of paternal mitochondria in 
the pre-implantation mouse embryo; and third, mitophagy of dysfunctional 
mitochondria at steady-state in cells lacking mitochondrial fusion. In particular, 
we explore the requirement for the mitophagy receptor protein, p62, in all of these 
processes, and show a novel cooperation between the newly identified 
mitochondrial resident E3 ligase, Mulan (MUL1), and the established 
PINK1/PARKIN mitophagy pathway. In the following sections we will briefly 
discuss elements of normal mitochondrial physiology, including mtDNA, 
respiration, and mitochondrial dynamics, and then focus on our current 
understanding of mitophagy, and one way in which the cell responds to their 
dysfunction.  
 
 3 
 
Respiration 
Energy production goes through three stages: glycolysis in the cytosol, the 
Krebs cycle in the mitochondrial matrix, and oxidative phosphorylation across the 
mitochondrial inner membrane. Glycolysis, which breaks down glucose into 
pyruvate, can proceed in the presence or absence of oxygen, and although it 
generates much less ATP than oxidative phosphorylation, it is the main energy 
generation method used by highly proliferative cells including tumor cells, as well 
as many immortalized cell lines in standard in vitro culture systems. This “aerobic 
glycolysis” is known as the Warburg effect (Diaz-Ruiz et al., 2011). The 
advantages of this metabolic switch are unknown; however, it is hypothesized that 
it may be advantageous in the hypoxic environment found within solid tumors 
(Gatenby and Gillies, 2004). Another feature of many tumor cells is glucose-
induced suppression of respiration, called the Crabtree effect (Crabtree, 1929). 
Both the Warburg and Crabtree effects are facilitated by the high glucose 
concentration often provided in cell culture media. Both are also reversible. 
Immortalized cells can be induced to increase respiration within 30 minutes of a 
shift in culture medium from glucose-containing to glucose-free medium that 
instead contains galactose or ketone bodies as a carbon source (Mishra et al.). 
This elevated respiration has a rapid effect on mitochondrial morphology. While 
cells grown in standard glucose-containing media have predominantly fragmented 
or short tubular mitochondria, within 24 hours of a shift to media lacking glucose, 
but containing galactose or ketone bodies, mitochondria form long tubules 
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(Mishra et al.). Metabolic state, therefore, profoundly affects mitochondrial 
physiology, beyond a simple increase or decrease in flow across the electron 
transport chain. Recent studies by our lab and others discussed below, and in 
Chapter 2, have begun to shed light on the fact that another physiological process, 
mitochondrial turnover by mitophagy, is also influenced by respiratory state 
(Melser et al., 2013). 
The Krebs cycle in the mitochondrial matrix generates the high-energy 
molecules NADH, and FADH2. Oxidative phosphorylation (OXPHOS) utilizes 
these high-energy molecules to generate an electrical potential across the inner 
mitochondrial membrane (IMM). This is accomplished by a series of coupled 
redox reactions that transport electrons through the respiratory complexes of the 
IMM. NADH enters the electron transport chain at complex I, and FADH2 enters 
at complex II. Electrons from these molecules are passed in a stepwise manner to 
eventually reduce O2 to H2O at complex IV. During this process protons move 
from the mitochondrial matrix to the intermembrane space, which creates an 
electrochemical gradient composed of a pH gradient, and an electrical potential. 
This potential drives the synthesis of ATP from ADP as protons flow through 
ATP synthase (complex V) and re-enter the matrix. Complex I is the primary 
point at which electrons enter the respiratory chain, and hence damage to complex 
I is detrimental to mitochondrial function (Brandt, 2006; Papa et al., 2008). Seven 
hydrophobic subunits, composing the central core of the complex I, are encoded 
by mtDNA, so mtDNA mutations often disrupt complex I function. Loss of 
complex I function has also been observed in mitochondrial fusion mutants, and 
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drugs that inhibit complex I function produce Parkinson’s-like disease phenotypes 
in animal models, and in humans (Chen and Chan, 2009; Chen et al., 2005). 
Mitochondria are the main source of reactive oxygen species (ROS) in the cell. 
Mitochondrial dysfunction due to mtDNA mutations or high respiratory activity 
can lead to oxidative stress, which results in oxidation of proteins, lipids, and 
DNA. Oxidative stress can induce mitochondrial degradation by mitophagy 
(Frank et al., 2012b), and may play a role in neurodegenerative diseases such as 
Parkinson’s (Henchcliffe and Beal, 2008; Uttara et al., 2009). Our understanding 
of the link between respiration and mitophagy, however, is incomplete, and 
further studies of the mechanisms by which OXPHOS leads to mitophagy are 
necessary.  
 
Mitochondrial DNA 
In the 1970s, Dr. Lynn Margulis proposed that mitochondria originated as 
endosymbionts - prokaryotic cells engulfed by a host cell, and maintained for 
their ability to undergo aerobic respiration. Consistent with this theory, 
mitochondria are the only animal organelles that carry their own DNA. The 
mitochondrial genome (mtDNA) consists of a roughly 16.6 kb double-stranded 
circular genome, which encodes 13 proteins, all of which are subunits of the 
respiratory chain complexes. These include seven subunits of complex I, one of 
complex III, three of complex IV, and two of complex V. mtDNA replicates 
independently from nuclear DNA, and requires its own mitochondrially-targeted 
machinery for this process. mtDNA also codes for 22 tRNAs and two rRNAs that 
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are required for mitochondrial protein synthesis (Reeve et al., 2008). The majority 
of mitochondrial proteins are encoded by the nuclear DNA, and transported to 
mitochondria by specialized import machinery described in more detail in the 
section on PINK1/PARKIN. Each mitochondrion contains one to ten thousand 
copies of its mtDNA, and these are arranged in nucleoids, a cluster of mtDNAs 
and proteins involved in replication and transcription. Mitochondria also contain 
their own DNA repair mechanisms; however, these are poorly understood, and 
mtDNA is subject to more mutations than nuclear DNA (Wei, 1998). The ROS 
generated in the mitochondria may contribute to this mtDNA damage. mtDNA is 
inherited exclusively through the maternal lineage (discussed in more detail in the 
section on paternal mitochondria), and mtDNA mutations are either inherited or 
acquired. mtDNA exists at high copy numbers, and this may help reduce the 
impact of mutations, which may exist in conjunction with wild-type mtDNA in a 
single mitochondrion. This mixture of mitochondrial haplotypes is known as 
heteroplasmy (Dimauro and Davidzon, 2005; Trifunovic and Larsson, 2008). 
Mitochondria reproduce by clonal expansion, and mtDNA is provided to daughter 
mitochondria by replication. Mitochondrial dysfunction can result when a certain 
threshold of mutant mtDNA is reached and usually manifests as defective 
OXPHOS (Rossignol et al., 2003). OXPHOS deficiency is particularly damaging 
for highly active cells that are dependent on ATP production, such as neurons, 
and skeletal and cardiac muscle cells. Thus mtDNA mutations are associated with 
encephalomyopathies, and neuromuscular disorders (Schapira, 2006). 
Additionally, the frequency of mtDNA mutations increases with age (Khrapko 
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and Vijg, 2009; Trifunovic and Larsson, 2008). Consistent with the deleterious 
effects of mtDNA mutations, recent evidence suggests that under conditions of 
heteroplasmy, mitophagy may be particularly important to remove dysfunctional 
organelles and reduce mutational burden (Dai et al., 2014). 
  
Mitochondrial Dynamics  
Mitochondria can take a vast array of shapes and sizes. In mouse 
embryonic fibroblast cells (MEFs) mitochondria usually exist as tubules of 
varying lengths. A variety of stressors, including temperature shock, and 
protonophore treatment, induce these mitochondria to fragment, forming the 
compact spherical organelles that are the classic textbook representation of 
mitochondria. Under conditions that favor aerobic respiration, these same 
mitochondria fuse and elongate to form a long tubular network. These 
morphology changes can occur as a part of normal physiology. In mouse oocytes 
and early embryos, mitochondria begin as compact, spherical organelles, and 
ultimately they elongate to form short tubules. Similarly, mitochondria in 
apoptotic cells are fragmented, while mitochondria from cells in the G1-S phase 
of the cell cycle exhibit elongated mitochondria (Barsoum et al., 2006; Jagasia et 
al., 2005; Mitra et al., 2009).   
These striking changes in morphology are due to the coordination of two 
opposing processes: fusion and fission of mitochondria (Detmer and Chan, 2007; 
Hoppins et al., 2007). These two processes are believed to strike a delicate 
balance in order to maintain healthy mitochondrial morphology and segregate 
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dysfunctional mitochondria from the rest of the network (Chen and Chan, 2009; 
Jezek and Plecita-Hlavata, 2009). In fact, our lab has recently shown that lethality 
due to defective mitochondrial fusion in mice can be rescued by an additional loss 
of mitochondrial fission (Chen et al., 2015).  
 
Mitochondrial Fusion 
Fusion is the process by which mitochondria join together forming 
filamentous networks. Mitochondria are composed of an outer and an inner 
membrane with an inter-membrane space between the two, and a matrix 
compartment within the inner membrane. Fusion of two mitochondria requires the 
junction of both the outer and the inner membranes, respectively. Therefore, the 
fusion process actually occurs as two separate fusion events, outer membrane 
fusion and inner membrane fusion, and each relies on dynamin-related large 
GTPase proteins. Mitofusin 1 and 2 (MFN1 and MFN2, Fzo1 in yeast) are 
together required for outer membrane fusion (Koshiba et al., 2004; Meeusen et al., 
2004). The MFNs are anchored to the outer mitochondrial membrane by two 
transmembrane domains such that both their N and C termini are exposed to the 
cytoplasm. MFN1 and MFN2 contain two 4,3 hydrophobic heptad repeat motifs, 
and the anti-parallel coiled coil interaction of the second of these domains on 
opposing mitofusins tethers the outer membranes of opposing mitochondria 
together during fusion (Koshiba et al., 2004). Homo- and heterotypic interactions 
between MFN1 and MFN2 have been observed (Chen et al., 2003; Rojo et al., 
2002), but in vitro, at least, the latter are more efficient (Hoppins et al., 2011). 
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While normally coupled to outer membrane fusion, inner membrane 
fusion is mediated by a distinct GTPase, Optic atrophy protein 1 (OPA1 or Mgm1 
in yeast) (Chen et al., 2005; Cipolat et al., 2004; Griparic et al., 2004; Meeusen et 
al., 2006; Olichon et al., 2003; Song et al., 2007; Song et al., 2009), and can be 
decoupled from outer membrane fusion. OPA1 is anchored to the inner membrane 
by a single transmembrane domain, and its C-terminus is exposed to the inter-
membrane space. In the absence of OPA1, fusion intermediates are observed that 
have distinct matrix units surrounded by a fused outer membrane, suggesting that 
inner and outer membrane fusion are truly distinct processes (Hoppins et al., 
2007; Song et al., 2009). OPA1 exists as a mixture of isoforms resulting from 
differential RNA splicing and proteolytic processing. Long isoforms contain the 
transmembrane domain whereas short isoforms do not (Chan, 2012; Delettre et 
al., 2001). Debate still exists as to which isoforms of OPA1 are minimally 
sufficient to undergo fusion. It was discovered that re-expression of either short 
isoforms or non-cleavable long isoforms of OPA1 in OPA1-null cells failed to 
rescue inner membrane fusion, whereas expression of a single cleavable long 
isoform was sufficient to reconstitute this process, suggesting that both long and 
short isoforms or the act of cleavage itself is required for inner membrane fusion 
(Song et al., 2007). However, other studies have shown that un-cleavable long-
form OPA1 is sufficient for fusion (Tondera et al., 2009), or that short-form 
OPA1 is actually involved in fission (Anand et al., 2014). A recent study in our 
laboratory suggests that long forms of OPA1 interact between opposing inner 
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membranes, while cleavage to short form dissolves this complex, thus facilitating 
fusion (Mishra et al., 2014). This matter remains open to further study. 
Mitochondrial fusion is the key process underlying mitochondrial 
morphology (Chen et al., 2003); however, it also plays a role in maintaining 
mitochondrial function and mtDNA stability, and is thought to protect the 
functional status of the mitochondrial population by facilitating content mixing 
amongst mitochondria (Chen et al., 2007; Chen et al., 2010; Detmer and Chan, 
2007). Inner membrane fusion is exquisitely sensitive to mitochondrial energetic 
status. Loss of mitochondrial membrane potential (ΔΨm) by protonophore 
treatment reduces mitochondrial fusion and induces proteolytic cleavage of OPA1 
(Chen et al., 2007; Duvezin-Caubet et al., 2006; Griparic et al., 2007; Ishihara et 
al., 2006; Song et al., 2007). It is speculated that this reduced fusion helps 
segregate dysfunctional mitochondria for degradation by mitophagy. 
Additionally, under endogenous conditions, mitochondrial fusion shows a 
selective preference for fusion between mitochondria with intact ΔΨm, suggesting 
that fusion may be a mechanism for separating active and inactive mitochondria 
for the same purpose. Conversely, high levels of mitochondrial fusion proteins 
reduce mitophagy (Twig et al., 2008). Work from our lab has shown that cells 
lacking mitochondrial fusion due to loss of MFN1 and MFN2 (MFN-null) have 
fragmented mitochondria as well as severe defects in respiratory capacity, cell 
growth rate, and ΔΨm (Chen et al., 2005). In these cells, the fragmented 
mitochondria become functionally heterogeneous, with widely divergent ΔΨm, 
protein levels, and mtDNA levels and mutation load. In mice, this dysfunction has 
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severe consequences. Loss of fusion proteins in all tissues is lethal, and loss of 
fusion exclusively in muscle cells results in a lethal mitochondrial myopathy 
(Chen et al., 2010). The fate of the dysfunctional mitochondria in MFN-null cells 
is unknown; however, recent evidence from our lab and others suggests that 
mitophagy may be upregulated in the absence of fusion (Narendra et al., 2008). 
Hence mitochondrial fusion may be viewed as a key mechanism for maintaining a 
healthy mitochondrial network and preventing mitochondrial degradation (Twig 
et al., 2008).  
 
Mitochondrial Fission 
Mitochondrial fission is an equally important mechanism for maintaining 
the integrity of the mitochondrial network. Fission itself is mediated by dynamin-
related protein (DRP1) (Smirnova et al., 2001). DRP1 is a cytosolic protein that 
must be recruited to mitochondria in order to facilitate division. A number of 
resident mitochondrial proteins can act as DRP1 recruitment factors and the 
varying roles of each is still under investigation. These include mitochondrial 
fission 1 (FIS1), mitochondrial fission factor (MFF), and mitochondrial dynamics 
protein 49 and 51 (MID49, MID51). Overexpression of these proteins increases 
DRP1 localization to the mitochondria (Gandre-Babbe and van der Bliek, 2008; 
James et al., 2003; Otera et al., 2010a; Palmer et al., 2011; Yoon et al., 2003; 
Zhao et al., 2011).  While FIS1 and MFF promote fission of mitochondria by 
DRP1, MID49 and MID51 reduce this activity by sequestering DRP1 (Dikov and 
Reichert, 2011; Palmer et al., 2011; Zhao et al., 2011). Interestingly, recent work 
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by our lab suggests that the suppression of fission by MID51 is dependent on 
nucleotide availability. When mitochondria are uncoupled with protonophore, 
carbonyl cyanide m-chlorophenylhydrazone (CCCP) or respiration is inhibited 
with complex III inhibitor, Antimycin A, and ADP is provided and MID51 
stimulates DRP1 oligomerization and fission (Loson et al., 2014). 
Like mitochondrial fusion, fission also plays a role in quality control of 
mitochondria. Fission generates two daughter mitochondria, and in so doing 
segregates functional contents into one daughter, and dysfunctional contents into 
the other, generating one hyperpolarized, healthy daughter, and one depolarized, 
dysfunctional daughter (Twig et al., 2008). In the latter, OPA1 and MFN levels 
are reduced, preventing the dysfunctional mitochondrion from fusing with healthy 
mitochondria within the cell. Instead, the damaged mitochondrion can now be 
selectively degraded by mitophagy. Indeed it is hypothesized that mitochondrial 
fission may be essential for mitophagy progression, as small fragmented 
mitochondria may be required in order for the phagophore to engulf the organelle.  
 
Mitophagy 
As illustrated above, mitochondrial physiology is complex and dynamic. 
Changes in respiratory state and morphology as well as mutations to mtDNA can 
drastically change the fitness of the mitochondrial population. Mitophagy is one 
of the primary means of responding to these changes in fitness. It enables 
dysfunctional mitochondria to be selectively degraded, preventing them from 
fusing with functional mitochondria in the cell, and reducing the impact of 
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damaging ROS they might produce. Mitophagy has been observed in a variety of 
different cellular contexts, including, but not limited to nutrient starvation, 
mitochondrial depolarization (due to physiologic or pharmacologic causes), 
increased OXPHOS, reduced fusion, erythrocyte differentiation, heteroplasmy, 
hypoxia, and fertilization. As more research is dedicated to this topic, this list 
continues to grow. Our understanding of the molecular mechanisms of mitophagy 
is in its infancy; however, new players in this process continue to be uncovered, 
and further studies will likely clarify what features are shared amongst these 
different forms of mitophagy, and which are unique. In the next section, we will 
begin by discussing the general process of macroautophagy, as the core 
components are utilized in the final stages of mitophagy. Then we will discuss the 
current understanding of the mechanisms by which mitophagy can be induced, 
and how these may interface with the core autophagy machinery. 
 
Macroautophagy 
Autophagy means “self-eating” and is a general mechanism for the 
degradation of cellular components by the lysosome. Autophagy can be divided 
into three classes: microautophagy, chaperone-mediated autophagy, and 
macroautophagy. The main distinction between the three lies in the mechanism by 
which contents arrive in the lysosome. Microautophagy involves the direct 
invagination of the lysosomal membrane and random incorporation of 
cytoplasmic material (Mijaljica et al., 2011). Chaperone-mediated autophagy is 
the pathway through which individual proteins containing a KFERQ-like 
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pentapeptide motif are transported across the lysosomal membrane by the 
cytosolic chaperone heat shock cognate 70 kDa protein (HSC70) and the 
lysosomal-associated membrane protein 2A (LAMP2A) (Kaushik and Cuervo, 
2008). Macroautophagy is the most morphologically distinct and best-studied 
pathway, in which specialized autophagosomal vesicles first engulf cargo and 
subsequently fuse with lysosomes. Hereafter macroautophagy will be referred to 
as autophagy. 
 
Autophagy Discovery 
Autophagy was first identified by electron microscopy. In characterizing 
developing kidney cells, Clark noted mitochondria within the degradative vesicles 
of brush border cells (Clark, 1957). Subsequently, Ashford and Porter found that 
perfusion of rat livers with glucagon induced an accumulation of lysosomes, 
almost all of which contained mitochondrial remnants (Ashford and Porter, 1962). 
Mechanistic studies revealed that during macroautophagy, double-membrane-
compartments formed around and sequestered cytoplasmic material. They were 
subsequently observed to acidify and display characteristics of lysosomes (Deter 
et al., 1967). These compartments are now called autophagosomes. Further 
immunoelectron microscopy studies identified the endoplasmic reticulum as the 
site of origin of autophagosomal membranes (Dunn, 1990); however, this model 
is still contested, and many alternative hypotheses exist, including the recent 
suggestion that under starvation conditions the mitochondria may be the source of 
autophagosomal lipids (Hailey et al., 2010).    
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Detailed genetic dissection of autophagy became possible with the 
discovery of the autophagy pathway in yeast in the early 1990s. When yeast cells 
were transferred to starvation media, autophagic bodies were observed to 
accumulate in the central vacuole. These vesicles contained cytoplasmic 
ribosomes, endoplasmic reticulum, and mitochondria, making them analogous to 
the autophagosomes observed in mammalian cells (Takeshige et al., 1992). The 
autophagy mutants identified in yeast are now referred to as the APG mutants 
(ATG in mammalian cells) (Thumm et al., 1994).  
The first mutant identified was apg1, in which nitrogen starvation in the 
presence of the protease inhibitor PMSF was lethal (Tsukada and Ohsumi, 1993). 
This enabled rapid screening, and the isolation of 16 complementation groups of 
apg mutants. Using an immunofluorescence assay for uptake of fatty acid 
synthetase into the vacuole, an independent group identified the same mutants, 
which they named aut mutants (Thumm et al., 1994). It is now appreciated that 
there are more than 30 autophagy genes. Of these, ATG1-10, 12-14, 16-18, 29, 
and 31 are essential for autophagosome formation (Nakatogawa et al., 2009). The 
proteins encoded by these genes can be functionally subdivided into six classes: 
the serine/threonine kinase, ATG1 (ULK1/2 in mammals), and its regulatory 
proteins, the PI3 Kinase complex, the transmembrane protein ATG9, the ATG2-
ATG18 complex, and two ubiquitin-like conjugation systems.  
 
Autophagy Mechanism 
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Autophagy begins with a degradation cue, such as ubiquitination of a 
substrate. Typically, when four or more ubiquitin molecules are linked by their 
K48 residues, they are recognized by the 19S proteasomal subunits and degraded 
by the proteasome (Elsasser and Finley, 2005). Ubiquitin chains with K63 or K27 
linkeages serve as signals for degradation by autophagy (Kraft et al., 2010). 
Evidence for the involvement of ubiquitin in autophagy is still emerging. A direct 
demonstration of this is that artificial substrates with ubiquitin chains can be 
recognized by the autophagy machinery and degraded in lysosomes (Kim et al., 
2008) A more indirect proof is that the degradation of excess ribosomes during 
nutrient starvation depends on the deubiquitinating enzyme UBP3/BRE5 (Kraft et 
al., 2008). Additionally, there may be other signals not yet appreciated, as 
ubiquitin independent mechanisms have been proposed. The ubiquitin-chains, and 
possibly other signals, are recognized by autophagy receptor proteins that can be 
broad or selective in scope. These receptors are generally believed to bind directly 
to core autophagy machinery at the isolation membrane. An autophagosome is 
formed around the substrate, and in mammals subsequently fuses with an 
endosome to generate an amphisome (in yeast, this step is skipped). The 
amphisome then fuses with the lysosome to form an autolysosome. Once the 
amphisome and lysosome fuse, the contents as well as the inner membrane of the 
autophagosome are subject to degradation (Armstrong and Hart, 1971; Baba et al., 
1995; Tooze, 2013). 
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Here we will briefly discuss the signaling mechanism in starvation-
induced autophagy and the biogenesis of the autophagosome, reserving a detailed 
discussion of signaling mechanisms to mitophagy specifically.  
 
AMPK and mTOR signaling in Starvation-induced Autophagy 
The first and best-understood pathway for autophagy induction is nutrient 
starvation. Starvation upregulates bulk autophagy in all organisms studied to date. 
The details of its signaling mechanism are still a topic of much investigation, but 
several key players are well established. UNC51-like kinase 1 (ULK1) must be 
phosphorylated in order to begin the “initiation” step of autophagy described 
below. Two kinases are known to regulate ULK1 phosphorylation, 5’ AMP-
activated protein kinase (AMPK), and mammalian target of Rapamycin (mTOR). 
AMPK is a sensor of cellular ATP levels, and its role in autophagy is dependent 
on glucose availability. The first illustration that AMPK directly impacts the 
autophagy pathway showed that under glucose starvation conditions AMPK has 
an activating effect on ULK1. A dominant-negative kinase-dead mutant of AMPK 
suppresses ULK1 autophosphorylation and wild type AMPK binds to ULK1, 
phosphorylates it at serine 317 and 777, and is sufficient to induce its 
autophosphorylation in vitro (Kim et al., 2011). ULK1 has been shown to be 
required for mitophagy caused by hypoxia or mitochondrial uncouplers; however, 
its role in other mitophagy systems has not been addressed (Wu et al., 2014).  
The role of mTOR, on the other hand, seems to be primarily in sensing 
amino acid levels. Under normal conditions, mTOR inhibits autophagy (Galluzzi 
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et al., 2014; Jung et al., 2010; Sengupta et al., 2010) and is itself strongly 
inhibited during amino acid starvation. Rapamycin, the mTOR inhibitor for which 
it is named, robustly induces autophagy even when nutrients are available (Noda 
and Ohsumi, 1998). mTOR forms two complexes, TOR complex 1 (TORC1) and 
TOR complex 2 (TORC2). TORC1 inhibits autophagy across model systems 
(Blommaart et al., 1995; Diaz-Troya et al., 2008; Noda and Ohsumi, 1998; 
Ravikumar et al., 2004; Scott et al., 2004). TORC1 was found to directly 
phosphorylate ULK1 on serine 757, a site distinct from ULK1 
autophosphorylation. This phosphorylation disrupts the interaction between 
ULK1 and AMPK (Kim et al., 2011). Furthermore, in yeast, TORC1 was shown 
to directly hyperphosphorylate ATG13, preventing its interaction with ULK1-
homologue, ATG1, and thereby inhibiting autophagy induction (Kamada et al., 
2010). The integration of AMPK and mTOR signals is complex and beyond the 
scope of this work, but both serve as a gateway to the next step in the pathway: 
autophagosome biogenesis.  
 
Autophagosome Biogenesis 
Autophagosome biogenesis roughly follows the stages outlined in Figure 
1.1, initiation, nucleation, and expansion. Upon activation of autophagy, a 
majority of ATG proteins accumulate at the pre-autophagosomal structure (PAS), 
which in yeast is a single punctate structure closely apposed to the vacuole. In 
mammalian cells, a similar structure may be found on the endoplasmic reticulum, 
called the omegasome (Itakura and Mizushima, 2010), but this remains to be 
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conclusively proven. At the PAS, proteins of the UNC51-like kinase (ULK) 
complex (ULK1, ULK2, ATG13, FAK family kinase interacting protein of 200 
kDa (FIP200) and ATG101) begin to form the isolation membrane (Lamb et al., 
2013). Now, a local pool of phosphatidylinositol 3-phosphate (PI3P) is formed 
when the activated ULK complex in turn activates a class III PI3K complex 
containing beclin 1 (ATG6 in yeast), vacuolar protein sorting 15 (VPS15), 
VPS34, and ATG14 (which, in mammals, may also be involved in fusion of the 
autophagosome to the late endosome) (Diao et al., 2015). Additionally, ATG9 
transmembrane protein helps traffic source membrane for phagophore elongation. 
Finally, a complex consisting of ATG5, ATG12, and ATG16 is recruited and it 
modifies microtubule-associated protein 1 light chain 3 (MAP1LC3, or just LC3, 
and ATG8 in yeast) by lipidation with phosphatidylethanolamine (PE). This 
allows LC3 to associate with the autophagosomal membrane, which is essential 
for autophagy progression.  
 
LC3, its processing, and function 
It is worth discussing LC3 in more detail, as it and its modifying proteins 
are essential for autophagy and it is used as a marker of autophagosomes in this 
work, as well as many others. The first mammalian ATG8 protein to be identified 
was LC3B, and was initially found associated with microtubule-associated 
proteins (MAPs) 1A and 1B (Kuznetsov and Gelfand, 1987). It was much later 
that its role in autophagy was identified (Kabeya et al., 2000). In humans there are 
actually two subfamilies of ATG8-like proteins: the LC3 family and the 
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GABARAP family.  The former consists of two splice variants of LC3A, LC3B, 
LC3B2 and LC3C, and the latter of GABARAP, GABARAPL1/GEC1, 
GABARAPL2/GATE-16, and GABARAPL3. All are ubiquitously expressed, but 
LC3B is the most commonly used for the study of autophagy. ATG8-like proteins 
share a common processing mechanism, which we will discuss in the context of 
the LC3 family (Shpilka et al., 2011).  
LC3 proteins are synthesized as precursor proteins and are proteolytically 
cleaved by ATG4 to reveal a conserved terminal glycine residue. This truncated 
form of the protein is called LC3-I, and is unable to associate with 
autophagosomes until it is lipidated in an ubiquitin-like conjugation pathway. 
Ubiqutitin-like modifier-activating enzyme ATG7 is an E1-like protein that 
activates ATG12 for its conjugation with ATG5 and ATG8 for its conjugation 
with PE. Ubiquitin-like conjugating enzyme ATG3 is an E2-like protein that in 
conjunction with the E3-like ATG12-ATG5-ATG16 complex covalently links PE 
to ATG8 (Ichimura et al., 2000; Tanida et al., 2003). This phospholipid 
conjugated ATG8, which runs as a faster migrating band on a denaturing 
polyacrylamide gel, is called LC3-II, and can be cleaved again by ATG4 to 
reverse the lipidation (Kabeya et al., 2004; Kirisako et al., 2000).  
Yeast ATG8 has no paralogues, and hence its essential role in autophagy 
was easily identified (Lang et al., 1998). By contrast, the redundancy within the 
mammalian system made this less obvious. More recent studies of ATG3 
knockout mice and cultured cells overexpressing a dominant-negative mutant of 
ATG4 have clarified that LC3 lipidation is essential for autophagy. ATG3 
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knockout mice exhibit a complete loss of LC3 conjugate formation, and electron 
microscopy shows aberrant isolation membranes that fail to close (Sou et al., 
2008). Furthermore, loss of ATG3 in mice is lethal at 1 day after birth, consistent 
with other studies showing a necessary burst of autophagy during the neonatal 
starvation period (Kuma et al., 2004). Dominant-negative ATG4 sequesters free 
LC3 and shows similar open isolation membranes as in ATG3-knockout mice as 
well as accumulation of LC3 due to lack of degradation in autophagosomes 
(Fujita et al., 2008).  
Historically, assessment of autophagy in vivo required electron 
microscopy, but more recently a variety of tools for probing autophagy have been 
developed. Although its precise function in autophagy is still unknown, LC3 was 
proposed as a good marker for monitoring autophagy. It is present exclusively on 
isolation membranes, autophagosomes, and to a lesser extent, autolysosomes, and 
unlike proteins upstream in the biogenesis pathway it does not dissociate from the 
isolation membrane when autophagosome biogenesis is complete, but instead 
remains on the membrane even after fusion with lysosomes (at which point the it 
becomes more dilute, and hence less easily detected) (Kabeya et al., 2000). For 
these reasons GFP-LC3 transgenic mice were generated which demonstrated that 
imaging of LC3 in tissues did not interfere with endogenous autophagic processes 
and could be used to indicate the distribution of autophagosomes in the cell 
(Mizushima et al., 2004).  
 
Autophagy Adaptors 
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Selective autophagy, such as mitophagy, often utilizes receptors that 
physically link labeled substrates with the canonical autophagy activation 
machinery. However, the mechanism of this interaction is still unclear, as direct 
binding to LC3 has been shown to be insufficient to recruit the phagophore in 
some cases (Itakura and Mizushima, 2011b). A class of adaptor proteins has been 
proposed which interact directly with ULK1. These include ATG11 in yeast, and 
Huntingtin (HTT) in Drosophila and mammals (Kamber et al., 2015; Rui et al., 
2015), forming a bridge between substrate receptors and the isolation membrane 
components. These adaptors may have regulatory roles as well, activating the 
autophagy machinery to localize isolation membrane formation to the areas of 
substrate availability. However, non-canonical autophagy pathways also exist 
which do not involve ULK1 or other core autophagy genes, and are indicative of 
how much more we have yet to understand about this topic.  
 
Mitophagy Machinery 
PINK/PARKIN Pathway 
The PINK1/PARKIN pathway of mitochondrial degradation is the best 
characterized form of mitophagy, and mounting evidence suggests that it is 
probably active in a number of different mitophagy contexts. The proteins 
involved in this pathway were first identified as genes mutated in familial forms 
of Parkinson’s disease (PD).  PD is a neurodegenerative disorder characterized by 
stereotypic motor symptoms, including bradykinesia, hypokinesia, cogwheel 
rigidity, resting tremor, and postural instability, and is the most common 
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movement disorder, and the second most common neurodegenerative disorder 
(Winklhofer and Haass, 2010). In PD, Loss of dopaminergic neurons in the 
substantia nigra pars compacta (SNPC) leads to a dopamine deficiency in the 
striatum, and the consequent dysregulation of basal ganglia circuitries underlies 
the motor symptoms. The disease can be sporadic or genetic in cause, and both 
forms exhibit loss of dopaminergic neurons in the SNPC; however, sporadic PD 
exhibits proteinaceous deposits within neuronal cell bodies (Lewy bodies) and 
processes (Lewy neurites), a characteristic observed much less frequently in 
genetic disease (Spillantini et al., 1997). Therefore, there may be both common 
and distinct mechanisms of cell damage in the two forms of PD. 
Sporadic PD is the most common form, and can be due to environmental 
(including pesticide exposure) or genetic factors. Little is known about the 
specific etiology of the disease and the pathogenesis is likely complex; however, 
identification of genes responsible for more rare familial forms of PD opened the 
field for more in depth research. Among these are autosomal dominant mutations 
in the gene encoding α-synuclein and leucine-rich repeat kinase 2 (LRRK2), and 
recessive mutations in the genes encoding parkin RBR E3 ubiquitin protein ligase 
(PARKIN), PTEN-induced putative kinase 1 (PINK1), protein deglycase DJ-1 
(DJ-1), and ATPase 13A2 (ATP13A2) (Di Fonzo et al., 2007; Ramirez et al., 
2006; Winklhofer and Haass, 2010).  
Mounting evidence suggests that mitochondrial dysfunction may be at the 
center of PD pathogenesis. In the late 1970s and early 1980s two separate reports 
were made of young drug addicts having developed Parkinsonism after 
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intravenous injection of a toxic byproduct of opioid synthesis. In both cases the 
neurotoxic compound was 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). 
Treatment with dopaminergic agents alleviated symptoms, and necropsy indicated 
damage to the SNPC without evidence of Lewy bodies (Davis et al., 1979; 
Langston et al., 1983). This finding is consistent with the degenerative pattern 
observed in non-human primates treated with MPTP (Forno et al., 1993; Hantraye 
et al., 1993; Moratalla et al., 1992; Varastet et al., 1994). The effects of dopamine 
agonist therapy in MPTP model systems and sporadic PD are similar, making it a 
common model for PD in laboratory studies, including in mice, where it has a 
similar, albeit milder effect (Betarbet et al., 2002).  
Studies of the molecular mechanism of MPTP-toxicity showed that a 
metabolite of MPTP, MPP+ concentrates in the mitochondria of neurons and 
inhibits Complex I causing ROS accumulation (Chan et al., 1991; Dreschel and 
Granger, 2009; Fabre et al., 1999; Hantraye et al., 1996; Hasegawa et al., 1990; 
Nicklas et al., 1985; Pennathur et al., 1999; Przedborski et al., 1996; Ramsay et 
al., 1986). Complex I dysfunction is also observed in post-mortem SNPD of 
sporadic PD patients (Janetzky et al., 1994) and subunits of complex I from 
frontal cortex mitochondria were found to be oxidatively damaged in autopsied 
patients with PD (Keeney et al., 2006) consistent with complex I dysfunction. 
Furthermore, rotenone, another inhibitor of complex I, induces α-synuclein-rich 
inclusion bodies like those observed in sporadic PD (Betarbet et al., 2000). Thus, 
evidence suggests that aberrant Complex I activity, and ROS may play a role in 
PD pathogenesis.    
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The etiology of mitochondrial dysfunction in sporadic PD is unclear, but 
some evidence points to elevated mtDNA mutation burden. Analysis of mtDNA 
in neurons from patients with PD showed higher levels of mtDNA deletions 
specifically in substantia nigra neurons than in age-matched controls (Bender et 
al., 2006). Additionally patients with rare mutations in mtDNA replication 
machinery, such as in the mtDNA polymerase POLG, or helicase Twinkle, exhibit 
parkinsonism (Baloh et al., 2007; Luoma et al., 2004), and variants in the POLG 
CAG-repeat region may predispose for sporadic PD (Luoma et al., 2007). There is 
no clear evidence that mtDNA mutations are actually causative of PD, they may 
instead occur as a result of increased cellular stress. Nonetheless, evidence is clear 
that mitochondrial dysfunction is sufficient to cause Parkinsonism across species 
and is associated with sporadic PD in patients. 
Familial variants of PD are essentially clinically indistinguishable from 
sporadic PD other than early onset and slower progression (Bonifati, 2007), and 
interestingly, current knowledge of the biology of PD related genes is consistent 
with the mitochondrial dysfunction, oxidative stress, and protein aggregopathy 
observed in sporadic PD. Mutations in PARKIN and PINK1 are the most 
common cause of autosomal recessive Parkinsonism (Valente et al., 2004). The 
first evidence that PARKIN and PINK1 operate as part of the same pathway came 
from drosophila. Deletion dParkin or dPink1 led to the same phenotypes: muscle 
degeneration, disrupted spermatogenesis, and loss of dopaminergic neurons. 
Conversely, overexpression of dParkin in the dPink1 null flies could partially 
rescue the defects, whereas overexpression of dPink1 in a dParkin null 
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background could not, suggesting that dPink1 functions upstream of dParkin. 
Swollen and fragmented mitochondria could be observed in the flight muscles of 
the mutant flies early in the disease progression, consistent with a role for 
mitochondria in onset of the pathology (Clark et al., 2006; Greene et al., 2003; 
Park et al., 2006; Whitworth et al., 2005; Yang et al., 2006). Oxidative stress was 
proposed as a root cause of the defects, as overexpression of glutathione S-
transferase could rescue dopaminergic neuron loss (Whitworth et al., 2005). In 
mice, loss of PARKIN or PINK1 also results in a common phenotype with 
mitochondrial and nigrostriatal dysfunction (Gautier et al., 2008; Kitada et al., 
2009; Palacino et al., 2004).  
PARKIN is a cytosolic E3 ubiquitin ligase, which is recruited to defective 
mitochondria and activated specifically upon mitochondrial depolarization 
(Narendra et al., 2008).  How mitochondrial dysfunction signals to PARKIN was 
recently uncovered, and involves an elegant cascade of proteolytic processing of 
the mitochondrial resident protein, PINK1. PINK1 is a serine/threonine kinase 
with an N terminal mitochondrial targeting signal (MTS). The majority of PINK1 
mutations found in PD impair the kinase activity, suggesting that this function 
might be important in maintenance of mitochondrial function (Silvestri et al., 
2005; Valente et al., 2004; Zhou et al., 2008).  A series of papers by Narendra et 
al. and others characterized the mechanism by which PINK1 recruits PARKIN 
selectively to depolarized mitochondria (Figure 1.2). By monitoring PINK1-YFP 
accumulation on mitochondria after treatment with CCCP, Narendra et al. found 
that full-length PINK1 accumulates on mitochondria within five minutes of 
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depolarization. When MFN-null MEFs, which have heterogeneous ΔΨm, were 
transfected with PINK1-YFP, the investigators found that PINK1 selectively 
labeled depolarized mitochondria. They further observed that PARKIN 
recruitment to depolarized mitochondria was dependent on PINK1 localization to 
mitochondria. No PARKIN localization was observed in PINK-null MEFs and 
this localization could be rescued by expression of exogenous PINK1 but not 
PINK1 lacking its N-terminal MTS (Narendra et al., 2010b). Ectopic PARKIN 
had been previously shown to induce mitophagy of depolarized mitochondria 
(Narendra et al., 2008), and with 24 hour treatment with CCCP loss of 
mitochondria could be quantified in WT MEFs. This loss was only achieved in 
PINK1-null MEFs with exogenous expression of PINK1 (Narendra et al., 2010b). 
Taken together, these results suggest that PINK1 is responsible for PARKIN 
recruitment to mitochondria. The selective recruitment of PARKIN to depolarized 
mitochondria was explained by biochemical analysis of PINK1 post-translational 
processing. Full-length PINK1, which is a 63 kDa protein anchored in the outer 
mitochondrial membrane, is cleaved to a 52 kDa cytosolic fragment that can be 
degraded by the proteome (Lin and Kang, 2008). Narendra et al. showed that in 
the presence of CCCP, levels of full-length PINK1 rise, whereas after CCCP is 
washed-out, levels of full-length PINK1 fall. In the presence of an ubiquitin 
proteasome system (UPS) inhibitor, MG132, levels of the 52 kDa short form of 
PINK1 rise, suggesting that this cleaved form is unstable under normal conditions 
(Lin and Kang, 2008; Narendra et al., 2010b). This data supports the model that 
PINK1 is cleaved and subsequently degraded under basal conditions. In the 
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setting of mitochondrial damage, however, full-length PINK1 is stabilized and 
able to recruit PARKIN, leading to degradation (Figure 1.2).  
Work by several other groups further detailed the proteolytic mechanism 
by which PINK1 serves as a signal of mitochondrial dysfunction. Under basal 
conditions, PINK1 is imported through the outer mitochondrial membrane 
(OMM) by the translocase of the outer membrane (TOM) complex and fed 
through the inner mitochondrial membrane (IMM) in the translocase of the inner 
membrane (TIM) complex, where it is first cleaved, as are most imported 
proteins, by the mitochondrial processing peptidase (MPP) (Greene et al., 2012). 
PINK1 is cleaved a second time by the rhomboid protease, presenilin-associated 
rhomboid-like protein (PARL) between amino acids A103 and F104 in its 
hydrophobic domain, which spans the IMM (Deas et al., 2011; Jin et al., 2010; 
Meissner et al., 2011). This cleavage product is the 52 kDa form of PINK1 that 
escapes to the cytosol where its N-terminal phenylananine is recognized by the N-
degron type 2 E3 ubiquitin ligases and degraded by the UPS (Yamano and Youle, 
2013). Thus, under basal conditions, very little PINK1 is detectable on 
mitochondria. However, stressors including mitochondrial depolarizing agents, 
OXPHOS inhibitors, genetic or environmental stress, or unfolded proteins prevent 
import of proteins through the TIM complex, and hence processing of PINK1 is 
blocked, since it never reaches the IMM where PARL and MPP reside. Full-
length PINK1 accumulates, bound to the Tomm7 subunit of the TOM complex, 
which has been suggested to be involved in releasing OMM proteins laterally into 
the OMM (Hasson et al., 2013; Lazarou et al., 2012; Okatsu et al., 2013). Indeed, 
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PINK1 contains a second, weaker targeting signal that directs it to the OMM 
(Zhou et al., 2008) and it may be by this domain that PINK1 is stabilized there. 
Alternatively, the association of PINK1 with the TOM complex might facilitate 
re-import and degradation should mitochondrial ΔΨm be restored. Making PINK1 
a switch turning mitochondrial degradation on or off (Lazarou et al., 2012). 
Many mitochondrial stressors result in loss of ΔΨm, and this may be a 
unifying mechanism for translation mitochondrial damage into targeted 
degradation. Mechanisms may exist, however, for degradation of mitochondria that 
do not involve depolarization. One such mechanism involves unfolded proteins in 
the mitochondrial matrix. In two recent papers, an unfolded protein expressed in the 
matrix stabilized PINK1 at the OMM and activated PARKIN without membrane 
depolarization (Jin and Youle, 2013). Accumulation of further unfolded protein by 
reduction in Lon protease, a matrix protease known to degrade unfolded proteins, 
further increased PINK1 accumulation (Jin and Youle, 2013). Similar experiments 
were performed in Drosophila where knockdown of LON protease also resulted in 
an increase in PINK1 on mitochondria (Thomas et al., 2014). However, differential 
sedimentation generating mitochondrial and postmitochondrial fractions from 
lysates of LON knockdown flies showed an accumulation of all processed forms of 
PINK1 in primarily the mitochondrial but also the postmitochondrial fractions. In 
contrast to the results in MEFs, this data suggests that LON might promote PINK1 
degradation in the matrix, a confounding finding in light of previous work, 
suggesting that PINK1 processed by PARL is primarily degraded in the cytoplasm 
(Yamano and Youle, 2013). The precise mechanism for PINK1 accumulation on 
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mitochondria due to unfolded mitochondrial proteins is still unknown, but in broad 
strokes it is clear that in both Drosophila and mammals mitochondrial damage 
results in PINK1 stabilization on the OMM and PARKIN activation (Pickrell and 
Youle, 2015). Until recently, it remained unknown how PINK1 recruits PARKIN to 
mitochondria and how PARKIN is activated. Co-immunoprecipitation experiments 
suggest that PINK1 and PARKIN directly bind one another (Sha et al., 2010; Xiong 
et al., 2009), however PINK1 and PARKIN appear predominantly in complexes of 
different sizes by size exclusion chromatography and native PAGE (Lazarou et al., 
2012; Thomas et al., 2011). Interestingly, ectopic expression of PINK1 on 
peroxisomes can recruit PARKIN to that organelle and induce pexophagy (Lazarou 
et al., 2012) suggesting that the substrate of Pink1 kinase activity is not specific to 
mitochondria. PINK1 has also been shown to directly phosphorylate PARKIN at a 
residue within its ubiquitin-like (UBL) domain (S65). This phosphorylation 
stimulates both PARKIN recruitment to mitochondria and E3 ligase activity 
(Kondapalli et al., 2012; Shiba-Fukushima et al., 2012). However, this 
phosphorylation event cannot be the sole mechanism for PINK1 mediated PARKIN 
recruitment to mitochondria, because mutant forms of PARKIN lacking the UBL 
domain, or mutated at S65 still translocate to mitochondria in PINK1 dependent 
manner (Kane et al., 2014). This data was somewhat confounding because it 
suggested that some other cytosolic substrate must be phosphorylated by PINK1, 
yet in vitro reconstitution of PARKIN activation could apparently be achieved with 
PINK1 and PARKIN alone (Lazarou et al., 2013). This conundrum was only 
resolved by a recent discovery that PINK1 phosphorylates ubiquitin at S65, and this 
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phospho-ubiquitin activates PARKIN (Kane et al., 2014; Kazlauskaite et al., 2014a; 
Koyano et al., 2014). This is perhaps not surprising given that the PARKIN UBL 
domain by its very nature is homologous to ubiquitin (Kondapalli et al., 2012). 
Several lines of evidence demonstrate that phospho-S65 ubiquitin mediates the 
activation of PARKIN by PINK1. First, mass spectrometry of PINK1-null cells 
compared to wild-type cells treated with CCCP showed that phospho-S65 ubiquitin 
was produced only in wild-type cells (Kane et al., 2014). Similar results were 
obtained in CCCP-treated cells with overexpression of PINK1 (Kazlauskaite et al., 
2014b). In a purified, cell-free system, PINK1 was shown to phosphorylate 
ubiquitin at S65 (Kazlauskaite et al., 2014b) and PARKIN was shown to bind to 
phospho-mimetic S65D ubiquitin (Kane et al., 2014). Phospho-ubiquitin could also 
activate PARKIN’s E3 ligase activity in vitro (Kane et al., 2014; Kazlauskaite et al., 
2014b) and a phospho-S65 mimetic PARKIN with an S65D mutation displayed 
greater ubiquitin ligase activity than wild-type PARKIN if it was incubated with 
phospho-ubiquitin, suggesting that phosphorylation not just of ubiquitin, but also of 
the PARKIN UBL could activate PARKIN (Kazlauskaite et al., 2014b; Koyano et 
al., 2014). However, while phospho-mimetic S65D ubiquitin alone was sufficient to 
activate PARKIN, phospho-mimetic S65D PARKIN was not active (Kane et al., 
2014; Kazlauskaite et al., 2014b). In live cells, replacing ubiquitin with an S65A 
phospho-incompetent mutant prevented PARKIN translocation to mitochondria 
(Kane et al., 2014), suggesting that phospho-ubiquitin is required for targeting 
PARKIN to mitochondria. One theory is that phosphorylation of existing ubiquitin 
chains on OMM proteins might be the first step in recruiting PARKIN. Consistent 
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with this, phospho-ubiquitin peptides could be isolated from peptides of OMM 
proteins by mass spectrometry (Kane et al., 2014). Ordureau et al. suggest a model 
with an additional role for direct phosphorylation of PARKIN. In this model, 
phosphorylation of PARKIN by PINK1 may occur first, localizing it to 
mitochondria and allowing it to begin ubiquitinating substrates, which then serve as 
the substrates for further phosphorylation by PINK1, and after being 
phosphorylated, these phospho-ubiquitin chains further accelerate PARKIN 
activity. In their immunoprecipitation experiments, PARKIN could bind 
phosphorylated ubiquitin with 21 times higher affinity if was also phosphorylated. 
Furthermore, it was found that the active site of PARKIN becomes exposed when 
PARKIN is activated by S65 phosphorylation but not when it is activated by 
phospho-S65 ubiquitin (Ordureau et al., 2014). This may indicate that PARKIN 
may first be directly phosphorylated by PINK1 before activation by phospho-S65 
ubiquitin. However, in vivo studies in Drosophila indicate that this may not be 
strictly necessary, since PINK1-null or PARKIN-null flies can be partially rescued 
even with a phospho-incompetent form of PARKIN (Shiba-Fukushima et al., 
2012). It remains unclear whether ubiquitin must be present on mitochondrial 
proteins to begin with and be phosphorylated by PINK1 in order to recruit 
PARKIN, or whether phosphorylation of PARKIN itself is enough to begin the 
process. The source of this ubiquitination, if not PARKIN, is yet unknown. 
PINK1 has been shown to phosphorylate other mitochondrial proteins; 
however, most are unrelated to mitophagy (Plun-Favreau et al., 2007; Pridgeon et 
al., 2007) and those involved in related processes (transport and dynamics) are not 
 
 33 
essential for mitophagy. MIRO1, a protein involved in mitochondrial trafficking on 
microtubules is phosphorylated by PINK1. This phosphorylation event was 
suggested to activate PARKIN-mediated proteasomal degradation of MIRO1, and 
hence arrest mitochondrial motility (Wang et al., 2011), but this result could not be 
replicated (Kazlauskaite et al., 2014a; Liu et al., 2012b). MFN2 was found to be 
phosphorylated by PINK1 leading to ubiquitination by PARKIN and degradation 
(Chen and Dorn, 2013); however, PARKIN translocation cannot be dependent on 
MFN2 because it proceeds normally in MFN-null cells (Narendra et al., 2008). 
Interestingly, Mitofusins are ubiquitinated in yeast lacking PINK1 and PARKIN 
(Neutzner et al., 2008), which is evidence that ubiquitinated proteins may be 
available on the OMM for PINK1 to phosphorylate prior to PARKIN translocation. 
Once on the mitochondria, PARKIN primarily forms K48- and K63-linked 
ubiquitin chains (Chan et al., 2011). K63-linked ubiquitin chains may be involved 
autophagy receptor recruitment, including p62 (Geisler et al., 2010; Narendra et 
al., 2010a; Okatsu et al., 2010; Sims et al., 2012; van Wijk et al., 2012) and NBR1 
(van Wijk et al., 2012), discussed below. K48-linked ubiquitin chains probably 
lead to extraction of proteins from the OMM (called outer mitochondrial 
membrane -associated degradation or OMMAD) and subsequent proteasomal 
degradation (Chan et al., 2011; Kim et al., 2013; Yoshii et al., 2011). However, it 
is not clear what role this may play in mitophagy, as proteasomal activity is 
necessary for PARKIN-mediated mitophagy (Chan et al., 2011; Tanaka et al., 
2010). Given the protective nature of mitochondrial fusion, alteration of the levels 
of MFN1 and MFN2 by PARKIN ubiquitination and proteasomal degradation 
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could play a role in accelerating mitophagy (Gegg et al., 2010; Poole et al., 2010; 
Tanaka et al., 2010; Ziviani et al., 2010). However, 36 OMM proteins have been 
shown to be ubiquitinated by PARKIN (Sarraf et al., 2013), which may indicate 
that the chain-linkage type and density of ubiquitin on mitochondria may be more 
important than the specific substrate. 
 
Other E3 Ligases 
There are three recently identified mitochondrial resident E3 ubiquitin 
ligases that could also facilitate mitophagy. Among these, one paper has proposed 
the OMM E3 ligase, RNF185, as a regulator of mitophagy (Tang et al., 2011). 
RNF185 was shown to ubiquitinate BCL family protein, BNIP1, with K63 
linkage, allowing it to bind to receptor p62 and recruit autophagosomes. This 
result has yet to be confirmed. Another OMM E3 ubiquitin ligase, Mulan (MUL1) 
can compensate for PARKIN activity and can ubiquitinate MFNs independently 
of PARKIN (Yun et al., 2014b); however, its role in mitophagy is not clear. The 
third mitochondrial resident E3 ligase is MARCH5, which has been shown to 
bind FIS1, DRP1, and MFN2, and has been proposed to regulate mitochondrial 
fission (Karbowski et al., 2007). A possible function in mitophagy remains to be 
addressed. Another non-mitochondrial E3 ligase has been proposed as a 
mitophagy player. When overexpressed, the ER resident Glycoprotein 78 (GP78) 
E3 ligase can induce degradation of mitochondria by autophagy that is PARKIN 
independent (Fu et al., 2013); however, this experiment was done in the setting of 
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CCCP treatment, which is non-physiological, so its true role in mitophagy is still 
tenuous.  
 
Receptors 
One common feature of many selective autophagy receptors is a short 
linear peptide sequence that binds directly to LC3, called the LIR motif (for LC3 
interacting region) (Alemu et al., 2012; Birgisdottir et al., 2013; Kalvari et al., 
2014). Canonical LIR domains are characterized by a [W/F/Y]XX[L/I/V] 
sequence (square brackets indicate alternative amino acids, X is any residue), and 
often follow acidic residues or phosphorylation sites, which exert a regulatory 
effect on LC3 binding. Selective autophagy receptors can be divided into two 
broad classes based on their ability to bind ubiquitin (Khaminets et al., 2016). 
Ubiquitin-dependent autophagy receptors contain ubiquitin-binding domains 
(UBD) by which they can recognize ubiquitylated substrates and physically link 
them to the LC3-II coated autophagosome via an LIR motif. However, whether 
this binding is required for their function is unknown. While the core autophagy 
machinery has been well conserved over evolution, selective autophagy 
machinery has expanded to allow for high specificity (Liu et al., 2014). Here we 
will discuss some of the machinery of the mammalian mitophagy system that is 
currently appreciated.  
 
Ubiquitin-dependent autophagy/mitophagy Receptors P62 and NBR1 
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Sequestosome 1 (SQSTM1) or p62 is a selective autophagy receptor with 
UBD and LIR domains as well as several specific protein interaction domains 
(Figure 1.3). Originally, p62 was identified as a cargo receptor for the selective 
removal of misfolded protein aggregates by autophagy (Bjorkoy et al., 2005; 
Komatsu et al., 2007; Pankiv et al., 2007), but more recently an additional role as 
a receptor for mitophagy has been elucidated (Geisler et al., 2010). The neighbor 
of BRCA1 (NBR1) shares sequence similarity with p62 and has a similar function 
as a receptor in removal of protein aggregates (Kirkin et al., 2009). Although 
NBR1 has been shown to be involved in pexophagy (Deosaran et al., 2013), and it 
was found by mass spectrometry on mitochondria undergoing mitophagy (Chan et 
al., 2011), its role in mitophagy is disputed (Shi et al., 2015). Both receptors are 
cytosolic under basal conditions, and contain a UBD at their C-terminus, which 
can bind polyubiquitin (Isogai et al., 2011). The NBR1 ubiquitin-associated 
(UBA) domain has equal affinity for K63- and K48-linked polyubiquitin chains, 
whereas, in the context of mitophagy, the p62 UBA domain shows strong 
preference for K63- and K27-linked polyubiquitin chains (Geisler et al., 2010) 
and its affinity is increased by phosphorylation at serine 403 (S403), within the 
UBA (Matsumoto et al., 2011), which is a novel type of autophagy regulation.  
In HeLa cells overexpressing wild type PARKIN and treated with CCCP, 
mitochondria exhibit K63-linked polyubiquitiation (Narendra et al., 2010a) and 
K27-linked ubiquitination (Geisler et al., 2010). This ubiquitination is dependent 
on PARKIN function, and can be abolished by overexpression of a ligase-dead 
PARKIN mutant R275W (Narendra et al., 2010a). Two separate groups of 
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investigators found that p62 is recruited to mitochondria when mitophagy is 
induced by mitochondrial depolarization with PARKIN overexpression (Geisler et 
al., 2010; Narendra et al., 2010a); however, these investigators differ in their 
interpretation of the role of p62 in mitophagy. By measuring the compaction 
index of mitochondria (proximity of mitochondria to the nucleus) in wild-type 
and p62 knockout MEFs, Narendra et al. conclude that P62 mediates the 
aggregation of mitochondria. However when this group counted the number of 
cells lacking mitochondria after CCCP treatment, in cells lacking p62 by either 
genetic knockout or siRNA, they found no difference relative to wild-type cells, 
indicating that p62 was not required for mitophagy (Narendra et al., 2010a). By 
contrast, when Geisler et al. performed the same experiment in p62 siRNA treated 
cells, they found significantly less clearance of mitochondria relative to wild-type 
cells, indicating that p62 was required for mitophagy (Geisler et al., 2010). 
Whether p62 is required for mitophagy or only for mitochondrial clustering has 
yet to be clarified, but in either case, it seems to be targeted to damaged 
mitochondria that are labeled with specific polyubiquitin chains.   
P62 contains an N-terminal PB1 domain which facilitates self-
oligomerization as well as binding to many other proteins. This domain is likely 
the means by which p62 aggregates form (Komatsu et al., 2007; Lamark et al., 
2003). It is believed that oligomerization increases the avidity of p62 for LC3B 
clusters, and it may also facilitate membrane curvature (Wurzer et al., 2015). 
NBR1 also oligomerizes, but it does so via its coiled-coil domain (CC1) (Kirkin et 
al., 2009). Hetero-oligomers of p62 and NBR1 as well as oligomers with other 
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proteins can also form (Lamark et al., 2003). Both receptors also contain LIR 
domains, which enable degradation of cargo as well as the receptors themselves 
via autophagy (Ichimura et al., 2008b; Rozenknop et al., 2011). NBR1 contains 
two LIR domains. The first, located N-terminal to its UBA domain (LIR1) 
interacts with LC3 and GABARAP subfamily proteins, whereas the more cryptic 
LIR between the two coiled-coil domains (LIR2) can provide redundant affinity 
for ATG8-homologues in the absence of LIR1 (Kirkin et al., 2009).  
Nix 
Nascent reticulocytes contain membrane-bound organelles including 
golgi, rough endoplasmic reticulum, endocytic vesicles, and mitochondria 
(Gronowicz et al., 1984; Koury et al., 2005). As they mature, reticulocytes lose all 
membrane-bound organelles, including mitochondria. NIX/BNIP3L is an outer 
mitochondrial membrane protein that mediates mitophagy during this maturation 
process (Sandoval et al., 2008; Schweers et al., 2007).  NIX is constitutively 
targeted to mitochondria by its C-terminal mitochondrial targeting sequence, and 
its cytosolic N-terminus contains an LIR motif like many autophagy receptors 
(Novak et al., 2010). Unlike most receptors, however, NIX may actually play a 
role in triggering mitophagy. A study of reticulocytes in NIX knockout mice 
showed that mitochondria persisted despite normal clearance of ribosomes, and in 
the absence of NIX mitochondria failed to colocalize with LC3 by 
immunostaining, consistent with a role as an LC3-binding receptor. However, 
flow cytometric analysis of reticulocytes stained with tetramethylrhodamine, ethyl 
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ester (TMRE), a cell permeant, positively-charged dye that accumulates in 
mitochondria with intact ΔΨm, showed that whereas wild-type reticulocytes 
exhibited depolarized mitochondria, mitochondria in NIX knockout reticulocytes 
maintained ΔΨm, indicating a role for NIX upstream of targeting to the 
autophagosome. Additionally, with treatment of NIX knockout reticulocytes with 
carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP), a protonophore 
that abolishes ΔΨm, mitochondria were cleared and could be seen in autophagic 
vacuoles, suggesting that some other mechanism exists to link defective 
mitochondria to the autophagosome downstream of NIX (Sandoval et al., 2008). 
This function places NIX in cooperation with the PINK1/PARKIN pathway of 
mitophagy, which targets depolarized mitochondria (Ding et al., 2010). In contrast 
to the role of NIX in erythrocyte maturation, wherein healthy mitochondria are 
targeted for degradation, the PINK1/PARKIN pathway targets only damaged 
mitochondria (Narendra et al., 2008). 
A new role for NIX was recently discovered in OXPHOS-induced 
mitophagy. High OXPHOS activity due to replacement of glucose with glutamine 
in cell culture media, was found to induce mitophagy revealed by a high rate of 
mitochondrial protein degradation and LC3 accumulation. Levels of the small 
GTPase, Ras homolog enriched in brain protein (RHEB) were found to increase 
under these conditions, and overexpression of RHEB could induce mitophagy 
even under normal growth conditions, consistent with a role for RHEB in 
triggering mitophagy. This mitophagy was found to be NIX dependent as well. 
Knockdown of NIX could prevent RHEB induced mitophagy, and a complex was 
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isolated that contained RHEB, NIX, and LC3. Under these conditions it was 
proposed that mitophagy enhances the efficiency of OXPHOS by removing 
damaged mitochondria (Melser et al., 2013). How increased OXPHOS translates 
to RHEB expression is unknown, and whether this condition also involves the 
PINK1/PARKIN pathway was not addressed. 
 
Stress induced mitophagy 
High OXPHOS activity may qualify as a form of energetic stress, since it 
demands high respiratory substrate concentrations, and creates elevated levels of 
ROS. This broader category includes starvation and mitochondrial dysfunction. In 
starvation, low nutrient availability leads to less ATP generation, whereas with 
inherent mitochondrial dysfunction, the low ATP generation is due to impaired 
synthesis. All these energetic stresses regulate mitophagy slightly differently, and 
although it is likely that they impinge upon the same core processes, a universal 
mitophagy pathway is yet to be identified. In the case of starvation, while 
autophagy is increased, as described previously, for the purpose of recycling 
nutrients, mitophagy is inhibited, probably to retain mitochondria to process the 
newly generated catabolites. Mitochondria avoid degradation in this case by 
elongation, sterically hindering engulfment by the autophagosome (Rambold et 
al., 2011). This is accomplished by inhibitory phosphorylation of DRP1 by 
Protein kinase A (PKA) due to rising cAMP levels, resulting in inhibition of 
fission. Mitochondrial dysfunction leading to PINK1/PARKIN activation does the 
reverse. PINK1 phosphorylation of MFN2 leads to its ubiquitination and 
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degradation, resulting in mitochondrial fragmentation and mitophagy (Chen and 
Dorn, 2013). These mechanisms illustrate a common link between energetic 
stress, mitophagy, and mitochondrial dynamics. Future work may identify a 
common pathway by which these factors are linked.   
Another type of cellular stress that impinges upon mitochondrial 
respiration is hypoxia. Recently, the OMM protein, FUNDC1, was shown to have 
mitophagy adaptor function under hypoxia (Liu et al., 2012a). Under normal 
conditions, FUNDC1 is phosphorylated in its LIR domain, inhibiting interaction 
with LC3. Hypoxia induces its dephosphorylation and promotes mitophagy, 
perhaps maintaining the proper stoichiometry of mitochondria given available 
oxygen. Additionally, expression of the NIX homologue, BNIP3, which also 
binds LC3, is induced under hypoxia, yet another means for reducing 
mitochondrial mass in the absence of oxygen (Hanna et al., 2012).  
 
Mitochondrial Fission and Mitophagy 
While mitochondrial fusion seems to be protective, there are several links 
between mitochondrial fission and mitophagy. In yeast, the DRP1 homologue, 
DNM1 is required for some types of mitophagy (Abeliovich et al., 2013; Frank et 
al., 2012a; Mao et al., 2013). Consistent with this, phenotypes due to deletion of 
dPink1 or dParkin in Drosophila can be reversed by enhancing mitochondrial 
fission (Deng et al., 2008; Yang et al., 2008). PINK1 and PARKIN have also been 
implicated in pinching off a newly identified class of vesicles, the so-called 
mitochondria-derived vesicles (MDVs), from mitochondria (Sugiura et al., 2014; 
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Yang and Yang, 2013). MDVs ultimately fuse with the lysosome for degradation. 
While it is not know whether other fusion machinery is involved in this process, 
this micro-fission event suggests yet another way that fission and mitophagy 
machinery may intersect. 
 
Fis1/TBC1D15 
Yet another interesting link between mitophagy and mitochondrial fission 
was recently identified in the protein FIS1. In yeast, the MDV1/FIS1 complex is 
the only adaptor for DRP1 on the mitochondria (Mozdy et al., 2000); however, in 
mammalian cells the situation is more complicated. FIS1 is conserved humans 
and mice, but as of now no one has been able to show a requirement for FIS1 in 
recruiting DRP1 to mitochondria. Instead, DRP1 recruitment is mediated by MFF, 
MID49 and MID51 (Koirala et al., 2013). There is still debate as to whether loss 
of FIS1 has any effect on mitochondrial morphology (Otera et al., 2010b). 
However, recently a FIS1 binding protein was identified that opened up new 
channels of investigation. RAB GTPase regulator domain-containing protein, 
TBC1D15, is a cytosolic protein that was shown to bind to FIS1 constitutively 
and regulate mitochondrial morphology independently of Drp1. Whereas 
knockdown of FIS1 has little obvious effect on mitochondrial morphology, 
knockdown of TBC1D15 causes more obvious elongation with or without FIS1 
knockdown, possibly pointing to an additional recruitment mechanism 
independent of FIS1 (Onoue et al., 2013). Subsequent work questioned the role 
for TBC1D15 in mitochondrial morphology and instead placed FIS1 and 
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TBC1D15 downstream of PINK1/PARKIN in restricting autophagosome 
biogenesis around mitochondria. Knockout of either FIS1 or TBC1D15 as well as 
a related protein, TBC1D17, impaired mitochondrial clearance by mitophagy, and 
led to accumulation of aberrantly structured LC3-labeled autophagosomal 
membranes during PINK1/PARKIN mediated mitophagy (Yamano et al., 2014). 
Similar results were seen in vivo in C. elegans where mutations in FIS1 also 
caused accumulation of LC3 aggregates and impaired mitochondrial clearance 
after treatment with Antimycin A (Shen et al., 2014). While it is intriguing to 
think that FIS1 may be a master mitophagy regulator on the mitochondria, it is 
unknown if the role of FIS1 and TBC1D15/TBC1D17 is restricted to mitophagy 
due to mitochondrial depolarization, or whether other types of mitophagy might 
also utilize this machinery.  
 
Mitophagy of paternal mitochondria during fertilization 
In humans and many mammals, mtDNA is maternally inherited, and hence 
mutations in mitochondrially-encoded genes follow the female line (Giles et al., 
1980). Such mutations may cause encephalomyopathies or other neuromuscular 
disorders (DiMauro and Schon, 2003), and have also been used as a molecular 
clock to date evolutionary events. Although heteroplasmy is not strictly avoided in 
mammals, as it can occur through random mutation, uniparental inheritance seems 
to be enforced nonetheless. Only one case of truly biparental inheritance in humans 
has ever been identified, and this finding has neither been reproduced in another 
laboratory, nor revealed by meta-analysis of previously identified heteroplasmic 
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sequences (Bandelt et al., 2005).  
The evolutionary rationale for this pattern of inheritance remains disputed. 
It has been suggested that maternal and paternal mtDNAs may be incompatible, 
that the disappearance of paternal mtDNA signal is actually due to dilution rather 
than degradation (Luo et al., 2013), or that mtDNA may be greatly damaged during 
transport in the sperm and hence must be degraded (Birky, 1995). PCR assays 
designed to detect paternal mtDNA reveal that whereas embryos from intraspecific 
crosses in mice never retain paternal mtDNA, it does persist in offspring of 
interspecific crosses, suggesting that neither incompatibility nor dilution are the 
only factors limiting paternal mitochondrial inheritance (Song et al., 2014). 
Additionally, one study of polyploid human embryos produced by IVF showed that 
occasionally paternal mtDNA can persist at least to the blastocyst stage in these 
faulty ova (St John et al., 2000), suggesting that under certain conditions an ovum 
may fail to restrict mitochondrial content, despite the fact that the ratio of maternal 
to paternal mitochondria remains imbalanced (Sawada et al., 2002).  
The mechanism behind this degradation in mammals is unknown; however, 
evidence exists supporting a role for selective proteolysis by the proteasome as well 
as for mitophagy. These may actually be related processes, as work from our lab 
and others suggest that activation of the proteasome may be a necessary step 
preceding mitophagy (Chan et al., 2011).  
Several mechanisms have been identified in different model systems that 
might also be active in mammals, some directed at the DNA itself and beginning 
during spermatogenesis. In Drosophila, mtDNA is removed from the spermatozoa 
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during its development in a process dependent on the mitochondrial endonuclease, 
EndoG (DeLuca and O'Farrell, 2012). Similarly, in Japanese Medaka fish the 
amount of mtDNA is reduced during spermatogenesis, and remaining mtDNA 
disappears during fertilization before the destruction of mitochondrial structures 
(Nishimura et al., 2006). Similarly, downregulation of mtDNA copy number has 
been found in rat, mouse, and human spermatogenesis (Rantanen et al., 2001; 
Rantanen and Larsson, 2000). This reduction seems to be important for sperm 
quality, as in human sperm, the ratio of mtDNA copies per cell in progressive 
verses nonprogressive sperm is estimated at 700:1200 (Diez-Sanchez et al., 2003).  
In mammalian fertilization, at least, mtDNA depletion is not the only 
mechanism. Ubiquitin signaling also clearly plays a role in mitochondrial 
degradation. In bovine, mouse, and primate eggs, sperm mitochondria are 
transiently tagged with ubiquitin during their development, and again after 
fertilization whereas oocyte mitochondria are not (Sutovsky et al., 1999). When 
anti-ubiquitin antibody is added to oocytes prior to fertilization, sperm 
mitochondria no longer become ubiquitinated and persist for at least 40 hours post 
fertilization by which point they would otherwise have been degraded (Sutovsky et 
al., 2000). The specific type of ubiquitin linkage on sperm mitochondria is 
unknown, and it may be a signal for the UPS, or mitophagy machinery.  
Activity of the ubiquitin-proteasome pathway in mitochondrial inheritance 
has been tested using proteasome inhibitors. Inhibition of the 26S proteasome with 
MG132 causes paternal mitochondria to remain intact for at least 120-hours. 
Importantly, however, MG132 also causes arrest of the cell cycle, and when the 
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treatment is removed and the cell cycle resumes, mitochondria proceed to 
degradation (Sutovsky et al., 2000). Since even in untreated embryos paternal 
mitochondria are not degraded until the four cell stage, these results remain 
inconclusive as to whether the effect of the proteasome on mitochondria is direct or 
somehow linked to cell cycle progression.  
Mitophagy represents an alternative pathway for paternal mitochondrial 
removal. Ammonium chloride (NH4Cl), a so-called “lysosomotropic agent”, is a 
weak base that increases intralysosomal pH, inhibiting protein degradation in the 
lysosome (Rote and Rechsteiner, 1983). When applied to bovine embryos 20 hours 
post-fertilization, NH4Cl prevents the destruction of the sperm mitochondria until at 
least the eight-cell stage, without inhibiting cell division, suggesting that lysosomal 
activity may also be required for loss of paternal mitochondria.  
Further support for mitophagy in fertilization comes from two recent studies 
in C. elegans that show accumulation of markers of the autophagosome around 
paternal mitochondria in early stage embryos and persistence of these mitochondria 
in mutant cells defective in autophagosome formation (Al Rawi et al., 2011; Sato 
and Sato, 2011). Similarly, fertilized mouse oocytes show accumulation of 
autophagosome markers around the sperm midpiece after but not before 
fertilization and lysosomes labeled with LysoTracker can be seen associated with 
sperm mitochondria inside the embryo (Sutovsky et al., 2000). Experiments with 
autophagy indicator mice, which contain a GFP-labeled autophagy protein, LC3, 
show that autophagy is involved in embryogenesis. No LC3 expression is seen in 
the egg prior to insemination, but dots of LC3 appear from the one to four-cell stage 
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after fertilization (Tsukamoto et al., 2008). Levels of GFP-LC3 rapidly decrease 
after the four-cell stage, which coincides with the final stage of paternal 
mitochondrial degradation. Accordingly, in matings where both egg and sperm are 
autophagy mutants, development does not proceed past the four to eight cell stage, 
precisely the point by which paternal mitochondria should be essentially cleared 
from the embryo (Tsukamoto et al., 2008). These data strongly suggest that 
mitophagy plays an important role in mitochondrial inheritance; however, studies 
are needed to conclusively show whether mitophagy is required for parental 
mitochondrial degradation in mammals. 
It is yet unknown what signals paternal mitochondria bear that distinguish 
them from maternal mitochondria, and what other requirements there may be that 
facilitate the degradation, such as mitochondrial morphology, given the previously 
discussed association between mitophagy and mitochondrial fission. The process of 
degradation must be highly specific, as paternal mitochondria persist in interspecies 
crosses. It is possible that the signal on paternal mitochondria involves one or more 
ubiquitinated proteins. So far the only mitochondrial protein that has been shown to 
be ubiquitinated in spermatozoa is Prohibitin, and it has both K48 and K63 types of 
ubiquitin chains so it could signal either the UPS or mitophagy machinery 
(Thompson et al., 2003). However, since this is an inner membrane protein, it is not 
the most probable candidate for a degradation signal. It is possible that bulk 
ubiquitination of mitochondria by an E3 ligase such as PARKIN may be required 
rather than ubiquitination of any specific proteins, and that upstream mechanisms 
dictate specificity, rather than the ubiquitination itself. Identification of further 
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ubiquitinated outer mitochondrial membrane proteins on sperm mitochondria will 
be informative. 
Measuring Mitophagy 
In the following chapters, we utilize fluorescence microscopy to measure 
mitophagy in MEF cells and mouse embryos. It is worth discussing here the 
various experimental methods for assessing mitophagy (as distinct from 
autophagy more broadly), as each has advantages and drawbacks. The gold 
standard is electron microscopy. Indeed, this was the method by which the 
process was first discovered. And although it enables visualization of 
mitochondria within double membrane vesicles, which is pathognomonic for 
mitophagy, it is nearly impossible to quantify, and a very difficult method to 
pursue. Loss of mtDNA nucleoids is one way to monitor mitophagy if combined 
with pharmacological or genetic perturbations of the autophagy pathway as a 
negative control. This method is specific for loss of mtDNA, but it does not 
always reflect mitophagy, and may be very noisy, as there are other methods for 
modulating mtDNA independent of mitophagy. One commonly used technique is 
to detect loss of mitochondrial outer membrane proteins such as TOM20 by 
western or immunostaining. This, however, cannot distinguish the loss of these 
proteins due to proteasomal degradation rather than mitophagy. Measurement of 
matrix proteins, by immunological methods or mitochondrial loading with ΔΨm-
independent dyes such as mitotracker green, is a more accurate assessment of 
mitophagy. Matrix proteins, however, are recycled at different rates, and may not 
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be very precise proxies for mitophagy. An alternative method is the expression of 
exogenous fluorophores targeted to the mitochondrial matrix. In Chapter 2 below, 
we utilize matrix-targeted Dendra2, a monomeric photoconvertable protein which 
fluoresces green under normal conditions, and can be photoconverted to red 
emission by exposure to UV light (Pham et al., 2012a). Loss of fluorescence of 
this matrix-targeted protein can be used as a reporter of mitochondrial 
degradation. Recently, a matrix-targeted fluorescent reporter using the coral-
derived protein Keima (mt-Keima), which exhibits pH-dependent excitation and 
resistance to lysosomal proteases, was used to measure mitophagy (Katayama et 
al., 2011). This is a more direct measure, since it changes its excitation 
wavelength from 440 to 586 in the acidic lysosome during autophagy, so a 
distinct population of mitochondria can be detected. Similar experiments have 
been done to monitor general autophagy, using LC3 tagged with both EGFP and 
mCherry based on the same principle, since mCherry is more acid-stable than 
EGFP (Gump et al., 2014). In our lab we have adapted this experiment to 
mitochondria, by targeting this fusion protein to the mitochondrial matrix, and we 
use this protein to assess mitophagy in Chapters two and three.   
 
Thesis Overview 
The importance of mitophagy in maintaining mitochondrial function is 
well appreciated. Studies in the last decade have clearly established a key role for 
PINK1 and PARKIN in mitochondrial quality control; however, it is not clear 
whether all or even most mitophagy pathways converge on PINK1/PARKIN. It is 
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increasingly becoming clear that there is a high degree of selectivity within the 
mitophagy system due to the array of receptors so far implicated in different 
mitophagy contexts. Selective mitophagy receptors can function by ubiquitin 
dependent or ubiquitin independent mechanisms, and since many have similar 
domain structures, it remains unknown how exactly the specificity is encoded in 
either case. Similarly, we do not know how much overlap there is mechanistically 
between mitophagy induced by different means. Further studies are needed to 
determine whether these are truly disparate pathways for mitophagy, or whether 
there are more universal rules governing mitophagy in mammalian cells. Toward 
this end, we developed three systems in which to study mitophagy: OXPHOS-
induced mitophagy in MEFs, degradation of paternal mitochondria in mouse 
embryos, and selective clearance of dysfunctional mitochondria within MFN-null 
cells. We utilized fluorescent reporters to directly analyze mitochondrial 
degradation in these systems, and we demonstrated a core set of proteins that 
function across systems in an effort to integrate our understanding of mitophagy 
in mammals.   
 
Chapter 2  
The maternal mode of mitochondrial inheritance in mammals is well 
accepted; however, the mechanism that governs loss of paternal mitochondria 
remains disputed. Although clear evidence in C. Elegans implicates mitophagy, it 
has not been conclusively shown that this is also the case in mammals. In an effort 
to directly test the role of mitophagy in mammalian fertilization, we took a two-
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staged approach. First, we developed a cell culture based system in which to 
identify candidate proteins involved in a physiological type of mitophagy induced 
by increased OXPHOS. Then, we tested the role of these proteins in mouse 
embryos by shRNA knockdown. We show that in both systems, the E3 ubiquitin 
ligases PARKIN and MUL1 play partially redundant roles in mitophagy, and that 
the process also requires FIS1, as well as the autophagy adaptor, p62 and PINK1. 
These results suggest that a core mitophagy mechanism, which may occur in 
response to a variety of stressors, is involved in the maternal transmission of 
mitochondria.   
 
Chapter 3 
Functional heterogeneity of mitochondria in cells lacking mitochondrial 
fusion has been previously described by our lab and others. MFN-null cells have a 
mixed population of healthy mitochondria and dysfunctional mitochondria that 
are depolarized, contain mtDNA mutations, altered protein content, and have 
reduced respiratory capacity. Some studies have suggested that the 
PINK1/PARKIN machinery is recruited to these dysfunctional mitochondria, but 
the means by which functional and dysfunctional mitochondria are distinguished 
has not been well addressed. Using our fluorescence based mitophagy assay, we 
show that MFN-null cells exhibit an increase in mitophagy, and that the 
mitophagy receptor, p62 is recruited specifically to defective mitochondria that 
lack mtDNA and ΔΨm. We further show that p62 is required for mitophagy in 
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these cells. Contrary to previous theories, we show that its ubiquitin-binding 
domain is dispensable for p62 recruitment to mitochondria. Rather, we find that a 
protein-protein interaction domain is sufficient to localize p62 to mitochondria, 
suggesting another layer of specificity in this mitophagy context.  
 
Chapter 4 
Here we discuss open topics in mitophagy based on the findings of the 
preceding chapters. We will address experiments that explore the role of MUL1 in 
mitophagy and specifically how it interacts with the PINK1/PARKIN mitophagy 
pathway. Next we will consider tools that are now available to study mitophagy 
including high-throughput methods, and the mitophagy mouse. Finally, we will 
discuss experiments focused on the long-term effects of paternal mitochondrial 
persistence in adult animals, addressing the puzzling reason why maternal 
inheritance of mitochondria came into being. 
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FIGURE LEGENDS 
 
 
Figure 1.1 Schematic of mammalian macroautophagy. Initiation at the 
phagophore assembly site (PAS) mediated by an ULK1-associated complex. 
Nucleation of the phagophore is mediated by the vacuolar protein sorting 34 
(VPS34) PI3K. Expansion of the phagophore membrane requires the conjugation 
of phosphatidyl ethanolamine (PE) to LC3 by way of two ubiquitin-like 
conjugation systems. The closed autophagosome fuses with the lysosome, 
forming the autolysosome.  
 
Figure 1.2 PINK1/PARKIN mitophagy pathway. Mitochondrial damage leads 
to impaired protein translocation through the mitochondrial outer membrane. 
PINK1 accumulates on the mitochondrial outer membrane, resulting in 
phosphorylation of ubiquitin and PARKIN. Phospho-ubiquitin activates PARKIN, 
which further ubiquitinates mitochondria. Ubiquitination triggers subsequent 
recruitment of the phagophore. FIS1 and TBC1D15 facilitate phagophore 
elongation and curvature around mitochondrial cargo. 
 
Figure 1.3 Domain structure of NBR1 and p62. The N-terminal Phox and Bem1 
(PB1) domain facilitates homo- and hetero-oligomerization of p62 and NBR1 as 
well as further protein-protein interactions. The zinc finger (ZZ) domain can bind 
DNA, and may modulate protein binding. The first NBR1 coiled coil domain (CC1) 
facilitates NBR1 homo-dimerization. Coiled-coil domain 2 (CC2) is of unknown 
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function. The LC3 interacting regions (LIR) of both proteins bind LC3 family 
proteins, with LIR1 of NBR1 having higher affinity than LIR2. The ubiquitin 
association domain (UBA) may facilitate binding to ubiquitinated autophagy 
substrates. The UBA of p62 has higher affinity for K63-linked ubiquitin chains, 
whereas the UBA of NBR1 shows equal affinity for K63 and K48-linked chains. 
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Figure 1.1
 
From (Kaur and Debnath, 2015)  
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Figure 1.2 
 
From (Pickrell and Youle, 2015)  
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Figure 1.3 
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ABSTRACT 
A defining feature of mitochondria is their maternal mode of inheritance. 
However, little is understood about the mechanism through which paternal 
mitochondria, delivered from the sperm, are eliminated from early mammalian 
embryos. We find that cultured mouse fibroblasts and early embryos use a common 
pathway for elimination of mitochondria. In both cases, mitochondrial elimination 
occurs by mitophagy, in which mitochondria are sequestered by autophagosomes 
and delivered to lysosomes for degradation. The E3 ubiquitin ligases PARKIN and 
MUL1 play redundant roles in elimination of paternal mitochondria. The process is 
associated with depolarization of paternal mitochondria and additionally requires 
the mitochondrial outer membrane protein FIS1, the autophagy adaptor P62, and 
PINK1 kinase. Our results elucidate the molecular mechanism of strict maternal 
transmission of mitochondria and uncover a collaboration between MUL1 and 
PARKIN in mitophagy.  
One Sentence Summary: Paternal mitochondria in mouse embryos are eliminated 
by a mitophagic process that requires the E3 ubiquitin ligases PARKIN and MUL1. 
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MAIN TEXT 
In most animals, including mammals, mitochondria are inherited strictly 
through the maternal lineage. Because sperm deliver mitochondria into the egg 
during fertilization, mechanisms must exist to eliminate paternal mitochondria from 
the early embryo. Uniparental inheritance of mitochondria ensures that only one 
haplotype of mitochondrial DNA (mtDNA) exists in the offspring, and this 
phenomenon underlies the maternal inheritance of mtDNA disease and the use of 
mtDNA to track human evolution. Mouse models suggest that heteroplasmy, the 
co-existence of more than one haplotype of mtDNA, is genetically unstable and 
associated with physiological abnormalities (1). In C. elegans, paternal 
mitochondria are eliminated by mitophagy (2, 3), whereby mitochondria are 
engulfed by autophagosomes and delivered to lysosomes for destruction. In D. 
melanogaster, paternal mitochondrial elimination involves autophagic components 
but occurs independently of Parkin (4), a Parkinson’s disease-related E3 ubiquitin 
ligase that is central to the most heavily studied mitophagy pathway. It is unclear 
whether these insights from invertebrate model organisms extend to mammals, 
where the role of autophagy or even an active mechanism in paternal mitochondrial 
loss has been challenged (5).  
We addressed this issue by first examining mitochondrial degradation in 
fibroblasts and then extending the study to early mouse embryos. To monitor 
mitophagy, we constructed a dual color fluorescence-quenching assay based on a 
mitochondrially localized EGFP-mCherry reporter. Normal mitochondria are 
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yellow, having both green and red fluorescence in the matrix, whereas mitochondria 
within acidic compartments show red-only fluorescence, due to the selective 
sensitivity of EGFP fluorescence to low pH. When mouse embryonic fibroblasts 
(MEFs) were cultured with a moderate concentration (10 mM) of glucose, a 
condition in which their metabolism relies largely on glycolysis, they showed few 
red-only mitochondria (Fig. 2.1A). We previously defined a glucose-free, 
acetoacetate-containing culture formulation that induces MEFs to upregulate 
OXPHOS activity (6). When cells were cultured for four days in this OXPHOS-
inducing medium, many cells exhibited numerous red puncta (Fig. 2.1A), consistent 
with a study showing that glucose-free conditions promote increased turnover of 
mitochondria (7). Atg3 knockout MEFs did not form red puncta under the 
OXPHOS-inducing condition (Fig. 2.1B-C), indicating that formation of red puncta 
is dependent on the core autophagy machinery. Consistent with this idea, the level 
of lipidated LC3, another core component of the autophagy pathway, was elevated 
(Fig. 2.1D). Moreover, the red-only puncta co-localized extensively with 
mTurquoise2-LC3B, suggesting that they represent mitochondrial contents within 
the autophagosome pathway. In addition, a subset of the red puncta co-localize with 
LAMP1, likely indicating later intermediates that have progressed to lysosomes 
(Fig. 2.1F). In contrast, in glycolytic medium, mTurquoise2-LC3B did not 
colocalize with mitochondria (Fig. 2.1E). In addition, we found that P62, a protein 
implicated in autophagy (8) and mitophagy (9), localized to mitochondria only 
under the OXPHOS-inducing condition (Fig. 2.1G). Unlike LC3B and LAMP1, 
however, P62 was localized to both red punctate mitochondria and elongated 
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yellow mitochondria. These results indicate that the OXPHOS-inducing condition 
results in an increase in mitophagy intermediates.  
With this cellular system, we sought to identify genes required for induced 
mitophagy. Previous studies suggested that mitochondrial dynamics, particularly 
mitochondrial fission, is important for efficient mitophagy (10, 11). To explore this 
idea, we examined the efficiency of OXPHOS-induced mitophagy in a panel of 
MEF cell lines deficient in mitochondrial fusion or fission genes: Mitofusin 1 
(MFN1), Mitofusin 2 (MFN2), both MFN1 and MFN2 (MFN-dm), Optic atrophy 1 
(OPA1), Mitochondrial fission factor (Mff), Dynamin-related protein 1 gene 
(Drp1), and Mitochondrial fission 1 (Fis1) (Fig. 2.2A). MEFs deficient in 
mitochondrial fusion were competent for mitophagy. In fact, MFN-dm cells and 
OPA1-/- cells showed substantial mitophagy even under glycolytic culture 
conditions, consistent with the finding that mitochondrial fusion protects against 
mitophagy (12, 13). Neither MFN-dm cells nor OPA1-/- cells were viable under 
oxidative conditions. Among cell lines deficient in mitochondrial fission, Drp1-/- 
and Mff-/- cells showed normal levels of mitophagy under OXPHOS conditions 
(Fig. 2.2A).  
In contrast, Fis1-/- cells had dramatically reduced mitophagy under 
OXPHOS conditions (Fig. 2.2A-B), and a failure of both P62 and LC3 to co-
localize with mitochondria (Fig. 2.2C-D). Although FIS1 is a central player in yeast 
mitochondrial fission, it does not play a prominent role in mammalian 
mitochondrial fission (14, 15). Instead, recent studies implicate FIS1 and its 
interacting protein TBC1D15 (16) in mitochondrial degradation, specifically in 
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PARKIN-dependent mitophagy (17, 18). Similar to Fis1 deletion, TBC1D15 
knockdown efficiently blocked mitophagy and decreased LC3 and P62 localization 
to mitochondria (Fig. 2.2C-E). Because depletion of either FIS1 or TBC1D15 
blocked mitophagy and abolished P62 localization to mitochondria, we tested 
whether P62 is required for mitophagy. Cells knocked down for P62, as well as p62 
knockout cells, were deficient for OXPHOS-induced mitophagy (Fig. 2.2C, E; Fig. 
2.S1A-B) and showed reduced mTurquoise2-LC3B localization to mitochondria. 
Conversely, expression of mTurquoise2-P62 restored red puncta formation in p62 
knockout cells, consistent with a role for P62 in OXPHOS-induced mitophagy (Fig. 
2.S1C). Taken together, these results place FIS1 and TBC1D15 upstream of P62 in 
promoting autophagic engulfment of mitochondria.  
Because PINK1 and PARKIN (PARK2) are central components of the most 
widely studied pathway for mitophagy (19), we tested the role of these molecules in 
our mitophagy assay. Pink1-/- cells showed a substantial reduction in OXPHOS-
induced mitophagy. Parkin knockout MEFs had normal mitophagy (Fig. 2.3A-B), a 
surprising observation given that PINK1 is known to operate upstream of PARKIN 
(20-22). This observation suggests that another molecule may compensate for the 
loss of PARKIN. Recently, the mitochondrial E3 ligase MULAN (MUL1/MAPL), 
has been shown to act in parallel to the PINK1/PARKIN pathway in ubiquitination 
and proteasomal degradation of mitofusin (23). We hypothesized that MULAN 
might work in parallel with PARKIN in OXPHOS-induced mitophagy, such that its 
presence would maintain mitophagy in the absence of PARKIN. Indeed, 
knockdown of MULAN by either of two independent shRNAs in the Parkin 
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knockout cell abolished mitophagy (Fig. 2.3A-B; Fig. 2.S1D). In contrast, loss of 
MULAN alone did not inhibit mitophagy. Inhibition of mitophagy due to loss of 
PINK1 or PARKIN/MULAN prevented co-localization of LC3 with mitochondria 
(Fig. 2.3C). These results reveal that MULAN and PARKIN have redundant 
functions in mitophagy. 
We found that mitochondria from cells grown in OXPHOS media are 
ubiquitinated at least two-fold more than cells grown in glycolytic media (Fig. 
2.3D,E). Loss of MULAN or PARKIN alone had little or no effect on the induction 
of mitochondrial ubiquitination under OXPHOS conditions. However, loss of both 
MULAN and PARKIN, or PINK1 alone, substantially reduced the ubiquitination of 
mitochondria, down to the level of glycolytic conditions (Fig. 2.3D,E). Taken 
together, these data suggest that MULAN and PARKIN act in concert to 
ubiquitinate mitochondrial substrates, and that a threshold level of ubiquitination 
may be required to sustain mitophagy under OXPHOS conditions. The level of 
mitochondrial ubiquitination is known to dynamically regulate mitophagy (24, 25). 
With these molecular insights from the cellular assay, we tested whether the 
same pathway is involved in elimination of paternal mitochondria in the early 
embryo. To track paternal mitochondria, we utilized male PhAM mice, in which all 
mitochondria, including those in the sperm midpiece, are labeled with a 
mitochondrially-targeted version of the photoconvertable Dendra2 fluorescent 
protein (26) (Fig. 2.S2A). When male PhAM mice were mated with wild-type 
females, the resulting embryos contained brightly fluorescent paternal 
mitochondria. At 12 hours post-fertilization (Fig. 2.S2B), the paternal mitochondria 
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were found in a linear cluster, reflecting their original organization in the sperm 
midpiece. At 36 hours after fertilization (Fig. 2.S2C), this cluster began to disperse 
in cultured embryos, and thereafter, individual mitochondria were dispersed in the 
blastomeres. Over the next 2 days, paternal mitochondrial content progressively 
decreased (Fig. 2.S2D-F). At 84 hours after fertilization, 60-80% of embryos had 
lost all paternal mitochondria and the average number of paternal mitochondria per 
embryo had dropped to less than 5 (Fig. 2.S2E).  
Because the time course of paternal mitochondrial loss was reproducible, 
we could test the role of the mitophagy proteins identified in our cell culture 
system. We microinjected 1-cell stage zygotes with lentivirus encoding mCherry 
and shRNA targeting mitophagy genes (Fig. 2.4A). Injected embryos began 
expressing the mCherry reporter within 48 hours of injection, 60 hours after 
fertilization (Fig. 2.S2G). We found that embryos expressing shRNA against P62, 
TBC1D15, or PINK1 showed strong suppression of paternal mitochondrial loss, 
compared to embryos expressing a non-targeting shRNA (Fig. 2.4B). When these 
mitophagy genes were knocked down, the majority of embryos retained five or 
more distinct clusters of paternal mitochondria (Fig. 2.4C). In contrast, less than 
20% of embryos containing non-targeting shRNA retained significant paternal 
mitochondria, with the majority of embryos showing complete loss of paternal 
mitochondria. Depletion of either PARKIN or MULAN alone modestly reduced 
paternal mitochondrial elimination, but depletion of both had a severe effect. 
Although FIS1 is a key molecule in the OXPHOS-induced mitophagy pathway, the 
relevant FIS1 molecules are likely to be contributed by the sperm and not the egg. 
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Our shRNA approach can only knockdown proteins synthesized within the embryo. 
To circumvent this issue, we developed a dominant negative version of FIS1 (FIS1-
DN) that lacks the C-terminal transmembrane domain. Retroviral overexpression of 
the FIS1-DN protein in MEFs strongly inhibits OXPHOS mitophagy (Fig. 2.S3A-
B). FIS1-DN shows diffuse cytosolic localization (Fig. 2.S3C), consistent with the 
role of the transmembrane segment in mitochondrial localization. When FIS1-DN 
was expressed in embryos, we found that loss of paternal mitochondria was 
strongly inhibited, with less than 20% of embryos showing loss of paternal 
mitochondria (Fig. 2.4D-E).  
The signal for selective degradation of paternal mitochondria in mammals is 
unknown, but some other forms of mitophagy are triggered by loss of 
mitochondrial membrane potential. Using the cationic dye TMRE 
(tetramethylrhodamine ethyl ester), we found robust staining of sperm isolated from 
the caudal epididymis of PhAM male mice, indicating intact mitochondrial 
membrane potential (Fig. 2.S4A,C). At 18 hours after fertilization, paternal 
mitochondria remained in a linear cluster and stained robustly with TMRE. 
However, over the next 36 hours, paternal mitochondria gradually lost TMRE 
staining, such that at 48 hours and later, nearly all paternal mitochondria failed to 
stain with TMRE, indicating a progressive and selective loss of membrane potential 
in paternal mitochondria (Fig. 2.S4B-C).  
Our results indicate that uniparental inheritance of mitochondria in mouse 
occurs through a mitophagic process that eliminates paternal mitochondria. We find 
that either PARKIN or MULAN is sufficient to promote this process and 
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OXPHOS-induced mitophagy in MEFs. The redundant function of MULAN likely 
explains why PARKIN knockout mice show surprisingly mild and inconsistent 
mitochondrial phenotypes (27, 28). Upon entering the egg, sperm mitochondria 
progressively lose membrane potential, likely triggering activation of the 
PINK1/PARKIN and MULAN pathways to selectively ubiquitinate these 
mitochondria. Although uniparental inheritance of mitochondria is nearly universal 
in animals, its physiological function remains mysterious. The identification of 
molecules essential for this process may facilitate examination of this issue. 
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MATERIALS AND METHODS 
Antibodies  
The following commercially available antibodies were used: anti-actin 
(Mab1501R, Millipore), anti-Hsp60 (SC-1054, Santa Cruz Biotech), anti-Lamp1 
(1D4B, Developmental Studies Hybridoma Bank), anti-P62 (PM045, MBL), anti-
LC3B (2775S, Cell Signaling), anti-c-Myc (C3956, Sigma), and anti-Ubiquitin 
(P4D1, Cell Signaling). 
 
Immunostaining 
For immunofluorescence experiments, cells were fixed with 10% formalin, 
permeabilized with 0.1% Triton X-100 and stained with the primary antibodies 
listed above and with the following secondary antibodies: goat anti-mouse Alexa 
Fluor 633, donkey anti-goat Alexa Fluor 546, goat anti-rabbit Alexa Fluor 488, goat 
anti-rabbit Alexa Fluor 633 (Invitrogen). When used, DAPI (d1306, Invitrogen) 
was included in the last wash.  
 
shRNA virus design and production 
For experiments in MEFs, the retroviral vector pRetroX-H1, which contains 
the H1 promoter, was used to express shRNAs. shRNAs were cloned into the 
BglII/EcoRI sites. For embryo injection experiments, a third-generation lentiviral 
backbone was used to express shRNAs. The lentiviral vector FUGW-H1 (29) was 
modified by replacing the GFP reporter gene with mCherry and changing the 
shRNA cloning sites from Xba/SmaI to BamHI/EcoRI, generating FUChW-H1. 
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For dual knockdown experiments in embryos, a second H1 promoter was added, 
along with XbaI/NheI cloning sites 3’ to the original H1 promoter, generating 
FUChW-H1H1.  
The shRNA target sequences were: 
p62: TGGCCACTCTTTAGTGTTTGTGT 
Tbc1d15: GTGAGCGGGAAGATTATAT 
Mulan sh1: GAGCTAAGAAGATTCATCT 
Mulan sh2:  GAGCTGTGCGGTCTGTTAA 
Pink1: GGCTGACAGGCTGAGAGAGAA 
Parkin:  CCTCCAAGGAAACCATCAA 
Non-targeting:  GACTAGAAGGCACAGAGGG 
 
Lentiviral vectors were cotransfected into 293T cells with plasmids 
pMDLG/pRRE, pIVS-VSVG, and pRSV-Rev. Retroviral vectors were 
cotransfected into 293T cells with plasmids pVSVG and pUMVC. All transfections 
were done using calcium phosphate precipitation. For microinjection, virus was 
collected, filtered, concentrated by ultracentrifugation at 25,000 rpm for 2 hours, 
resuspended in PBS and stored at -80°C as described previously (30, 31). Viral 
titers were measured by infecting MEFs with serial dilutions of viral preparations, 
followed by flow cytometric analysis after 48 hr. Virus was used at 1x107 
transducing units/μL.  
 
Embryo microinjection 
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All mouse work was done according to protocols approved by the 
Institutional Animal Care and Use Committee at the California Institute of 
Technology. For each experiment, four C57/Bl6J wildtype female mice at 21-25 
days old were superovulated by hormone priming as described previously (31), and 
then each was caged with a PhAM male (26). After euthanization of females by 
CO2 asphyxiation, the embryos were harvested and placed in M2 medium (MR-
015-D, Millipore) at 12 hours after fertilization as described in (31). Approximately 
60 to 100 embryos were collected per experiment. Embryos were divided into two 
equal groups and microinjected with 10 to 100 pl of viral stock into the perivitelline 
space as described in (30, 31). Embryos were washed with KSOM+AA medium 
(MR-106-D, Millipore) and cultured in that medium covered by oil (M8410, 
Sigma) at 37°C and 5% CO2. For each construct, at least three separate 
microinjection sessions were performed. In preparation for imaging, embryos were 
transferred to 10 μl droplets of KSOM+AA medium on glass-bottom dishes (FD35-
100, World Precision Instruments). 
 
Imaging 
All images were acquired with a Zeiss LSM 710 confocal microscope with 
a Plan-Apochromat 63X/1.4 oil objective. All live imaging was performed in an 
incubated microscope stage at 37°C and 5% CO2. The 488 nm and 561 nm laser 
lines were used to excite cox8-EGFP-mCherry and imaging was done in line mode 
to minimize movement of mitochondria between acquisition of each channel. The 
405 nm laser line was used to excite mTurquoise2 and DAPI. Alexa 488, Alexa 
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546, and Alexa 633, conjugated dyes were excited by the 488 nm laser, 561 nm 
laser, and the 633 nm laser, respectively.  
For embryo imaging, optical slices were acquired at 1.1-μm thickness, and z 
stacks were oversampled at 0.467 μm. The 488 nm laser line was used to excite 
Dendra2 in the unconverted state. The mercury lamp was not used to avoid 
photoconversion. The same settings were used across all embryo-imaging 
experiments. Zen 2009 image analysis software was used to produce maximum 
intensity z-projections.  
 
Isolation of spermatocytes 
Sperm were isolated from 4-month-old PhAM male mice. Longitudinal cuts 
were made in the cauda epididymis and the tissue was incubated in PBS at 37°C to 
enable motile, mature sperm to swim out.  
 
Membrane potential measurements 
TMRE fluorescence was used to monitor mitochondrial membrane potential 
in spermatocytes and embryos. Samples were loaded with 20 nM TMRE for 20 min 
at 37°C and then washed into PBS (spermatocytes) or KSOM+AA (embryos). 
Samples were imaged live. Line analysis was performed using ImageJ.  
 
Isolation of mitochondria 
Mitochondria were isolated by differential centrifugation. Cells were 
washed in PBS, collected by scraping in isolation buffer (220 mM mannitol, 70 
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mM sucrose, 80 mM KCl, 5 mM MgCl2, 1 mM EGTA, 10 mM K+HEPES, pH7.4, 
and HALT protease inhibitors), and lysed on ice via sonication (amplitude 5, 5 
seconds on, 5 seconds off, 3 cycles). Lysates were cleared of cell debris and nuclei 
with four 600 g spins. A crude mitochondrial fraction was isolated with a 10,000 g 
spin for 10 minutes and washed three times in isolation buffer. 
 
Retroviral expression constructs 
The Cox8-EGFP-mCherry retroviral vector (kindly provided by Dr. 
Prashant Mishra) consists of the Cox8 mitochondrial targeting sequence placed N-
terminal to an EGFP- mCherry fusion. To clone mTurquoise2 fusion proteins, 
mTurquoise2 was amplified from pmTurquoise2-Mito (Addgene plasmid # 36208, 
Dorus Gadella, (32)). Human LC3B was amplified from pFCbW-EGFP-LC3. 
Mouse P62 was amplified from pMXs-puro GFP-p62 (Addgene plasmid # 38277, 
Noboru Mizushima, (33)). mTurquoise2 fusion proteins were cloned into the 
retroviral vector, pBABEpuro. The FIS1 dominant negative construct was cloned 
into pBABEpuro and consists of amino acids 1-121 of mouse FIS1, with 9 Myc 
tags at the N-terminus. The corresponding control construct consists of mCherry 
cloned into the pBABEpuro vector. All plasmids were verified by DNA sequence 
analysis. Stable cell lines were generated by retroviral infection followed by 
selection with 2 μg/μl puromycin.  
 
Cell culture 
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MEFs were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin and 100 
U/mL streptomycin at 37°C and 5% CO2. Glucose and acetoacetate containing 
media were made as previously described (6). For mitophagy experiments, cells 
were plated on Nunc Lab-Tek II Chambered Coverglass slides (155409, Thermo) in 
DMEM-based media. After cells had adhered, they were washed with PBS and 
glucose- or acetoacetate-containing medium was applied, after which cells were 
allowed to grow for four days and then imaged. Because cells grow more slowly in 
acetoacetate medium, a four-fold excess of cells was plated relative to glucose 
medium so that both samples were at the same density on the day of imaging.  
 
Cell lines 
The cells used included: Atg3-null MEFs (34) (kindly provided by Yu-Shin 
Sou and Masaaki Komatsu), p62-null MEFs (35) (kindly provided by Shun 
Kageyama and Masaaki Komatsu), Pink1-null, Parkin-null (both kindly provided 
by Clement Gautier and Jie Shen), and Drp1-null (36) (kindly provided by 
Katsuyoshi Mihara). MFN1-null, MFN2-null, MFN-dm, OPA1-null, Mff-null, and 
Fis1-null MEFs have been described previously (15, 37). 
 
Analysis 
Images were cropped when appropriate and image contrast and brightness 
were globally adjusted in Photoshop (Adobe). All quantifications were scored in 
triplicate with greater than 100 cells per experiment. 
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Western densitometry analysis was done using ImageJ. Density of ubiquitin 
signal was normalized to density of Hsp60 signal and the average of three separate 
experiments was taken.  
For quantification of paternal mitochondria, maximum intensity z stacks 
were scored as having greater than 5, less than 5, or no distinct green puncta. 
Embryos from four females were pooled per experiment, and three or more 
independent replicate experiments were averaged.  
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FIGURE LEGENDS 
Figure 2.1 Induction of mitophagy by OXPHOS-inducing medium. Mitophagy 
was examined in cells stably expressing Cox8-EGFP-mCherry. Wildtype (A) or 
Atg3 knockout mouse embryonic fibroblasts (MEFs) (B) were grown in Glucose 
(Glu) or Acetoacetate (Ac) containing medium for four days and then imaged by 
fluorescence microscopy. The red puncta in (A) represent mitochondrial contents 
within acidic compartments. (C) Quantification of red-only puncta. **, p <0.01. (D) 
Western blot analysis of LC3B expression in MEFs cultured in the indicated 
medium. Actin is a loading control. (E) Co-localization of LC3B with red puncta. 
MEFs expressing cox8-EGFP-mCherry and mTurquoise2-LC3B were grown in the 
indicated medium and imaged by fluorescence microscopy. Arrows indicate 
examples of mTurquoise2-LC3B co-localization with red mitochondrial puncta. (F) 
Co-localization of LAMP1 with red puncta. MEFs stably expressing cox8-EGFP-
mCherry were grown in acetoacetate-containing medium and immunostained with 
anti-Lamp1 antibody (blue). Arrows and asterisks indicate red mitochondrial puncta 
that co-localized, or not, respectively, with LAMP1. Scale bar in (A) is 10 m and 
applies to (A-F). (G) Co-localization of P62 with mitochondria. MEFs were grown 
in the indicated medium and immunostained with anti-P62 (green) and anti-HSP60 
(red, mitochondrial marker). Error bars indicate SD. Scale bar, 10 μm. 
 
Figure 2.2 Mitophagy under OXPHOS-inducing conditions requires Fis1, 
TBC1D15, and P62. (A) Mitophagy in cells with mutations in mitochondrial 
dynamics genes. MEFs of the indicated genotype were cultured in glucose or 
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acetoacetate medium, and mitophagy was quantified using the Cox8-EGFP-
mCherry marker. (B) MEFs stably expressing Cox8-EGFP-mCherry were grown in 
acetoacetate containing medium and then imaged by fluorescence microscopy. p62 
and Tbc1d15 shRNAs were stably introduced by retroviral infection. (C) Co-
localization of mTurquoise2 with mitochondria. MEFs were grown in acetoacetate 
containing medium. Note that mTurquoise2 puncta localize to mitochondrial puncta 
only in WT cells. (D) Co-localization of P62 with mitochondria. MEFs were grown 
in acetoacetate containing medium and immunostained with anti-P62 (green) and 
anti-HSP60 (red). (E) Quantification of red-only puncta in WT cells and cells 
containing shRNA against Tbc1d15 or p62 cultured in glucose (Glu) or 
acetoacetate (Ac) medium. Error bars indicate SD. 
 
Figure 2.3 MULAN and PARKIN have redundant functions in OXPHOS-
induced mitophagy. (A) Quantification of red-only puncta in cells grown in the 
indicated medium. Presence (+) or absence (-) of Pink1 gene, Parkin gene, or 
Mulan mRNA is indicated. (B) Mitophagy in wildtype and mutant cells. Cells 
stably expressing Cox8-EGFP-mCherry were grown in acetoacetate-containing 
medium and imaged by fluorescence microscopy. (C) Co-localization of LC3B 
with mitophagy intermediates. Wildtype and mutant cells were retrovirally 
transduced with mTurquoise2-LC3B, grown in acetoacetate containing medium and 
imaged by fluorescence microscopy. (D) Accumulation of polyubiquitinated 
proteins in mitochondria. Cells were grown in the indicated medium, and 
mitochondria were isolated by differential centrifugation. Mitochondrial lysates 
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were analyzed by Western blot for pan-Ubiquitin. HSP60 is a loading control. (E) 
Quantification of polyubiquitinated proteins in mitochondria. Three independent 
experiments were quantified by densitometry and averages are shown. Ubiquitin 
level was normalized to HSP60. Error bars indicate SD. 
 
Figure 2.4 Clearance of paternal mitochondria in preimplantation embryos 
requires mitophagy genes. (A) Schematic of paternal mitochondrial elimination 
assay. Wildtype females are mated with PhAM males, whose sperm donate 
Dendra2-labeled mitochondria to the embryo upon fertilization. One-cell embryos 
are microinjected in the perivitelline space with concentrated lentivirus targeting 
candidate genes. During in vitro culture, embryos are periodically imaged live and 
monitored for loss of paternal mitochondria. (B) Clearance of paternal mitochondria 
upon inhibition of mitophagy genes. Embryos were injected with lentivirus 
targeting the indicated shRNA. The mitochondrial Dendra2 signal was imaged in 
live embryos by fluorescence microscopy at 60, 72, or 84 hours after fertilization. 
Images are maximum intensity projections. Scale bar, 10 μm. (C) Quantification of 
paternal mitochondrial elimination at 84 hours post-fertilization. Embryos were 
scored as having no paternal mitochondria (black bar), less than five clusters (white 
bar), or greater than five clusters (grey bar). Average of three independent injection 
experiments is shown. Error bars indicate standard deviation. (D) Clearance of 
paternal mitochondria in embryos expressing mCherry (control) or Fis1-DN. Same 
scale as (B). (E) Quantification of 84 hour results from (D). *p, <0.05; **, p<0.01; 
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***, p<0.001 (Student’s t-test). p-values compare experimental embryos to control 
embryos with non-targeting shRNA or mCherry control. Error bars indicate SD.  
 
Figure 2.S1 Defective mitophagy in p62 and Parkin/Mulan deficient cells. (A) 
Quantification of red-only puncta in wildtype or p62 knockout cells grown in 
medium containing glucose (Glu) or acetoacetate (Ac). Error bars indicate SD. (B) 
Representative image of p62 knockout cell expressing cox8-EGFP-mCherry. Cells 
were grown in medium containing acetoacetate and imaged by fluorescent 
microscopy. Scale bar, 10 μm. (C) Rescue of mitophagy by P62 replacement. p62 
knockout cells stably expressing cox8-EGFP-mCherry were transduced with 
mTurquoise2-P62, grown in acetoacetate (Ac) containing medium, and imaged by 
fluorescence microscopy. Arrow indicates mitochondrial localization of 
mTurquoise2-P62. (D) Requirement for Parkin/MULAN in mitophagy. 
Quantification of red-only puncta in cells grown in medium containing 
acetoacetate. Wildtype (+) or Parkin knockout (-) cells were transduced with one of 
two independent MULAN shRNAs as indicated. Error bars indicate SD. 
 
Figure 2.S2 Paternal mitochondria are degraded by 84 hours after 
fertilization. (A) Fluorescence of mito-Dendra2 in a live spermatocyte isolated 
from the cauda epididymis of a PhAM mouse. Scale bar, 10 μm. (B) Mito-Dendra2 
in a 12-hour embryo. Note that mito-Dendra2 is circumscribed to a distinct rod-like 
structure. (C) Mito-Dendra2 in a 24-hour embryo. Note that mito-Dendra2 appears 
as puncta dispersed from the rod-like structure. Scale bar, 20 μm. (D) Mito-
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Dendra2 in an 84-hour embryo. Note that distinct mito-Dendra2 puncta are lost. 
Scale bar, 10 μm. (E) Paternal mitochondrial elimination in control embryos 
injected with non-targeting shRNA. Mito-Dendra2 clusters were quantified at 36, 
60, 72, and 84 hours after fertilization. Each data point represents the mean of 15 
embryos. Error bars indicate SD. (F) Representative images of embryos analyzed in 
(E). Scale bars, 10 μm. (G) mCherry expression in embryos from (F). Note that 
mCherry expression is visible by 60 hours after fertilization. Bright aggregates at 36 
and 60 hours are debris from viral prep, not from embryonic expression. Scale bars, 
10 μm.  
 
Figure 2.S3 Inhibition of OXPHOS-induced mitophagy by dominant negative 
FIS1. (A) Quantification of red-only puncta in wildtype (WT) cells or cells 
transduced with MYC-FIS1-DN retrovirus. Cells were grown in medium 
containing glucose (Glu) or acetoacetate (Ac). **, p<0.01 (Student’s t-test). Error 
bars indicate SD. (B) Imaging of cox8-EGFP-mCherry in WT cells or cells 
transduced with MYC-FIS1-DN retrovirus. Cells were grown in medium 
containing acetoacetate. Scale bar, 10 μm. (C) Diffuse cytosolic localization of 
MYC-FIS1-DN. Scale bar, 10 μm. 
 
Figure 2.S4 Membrane potential lost in paternal mitochondria after 
fertilization. (A) Mitochondrial membrane potential in live sperm cell. 
Spermatozoa were isolated from the cauda epididymis of a PhAM mouse, stained 
with 20 nM TMRE, washed, and imaged by fluorescent microscopy. Red signal is 
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TMRE; green signal is mito-Dendra2. The boxed region is enlarged below. Scale 
bar, 10 μm. (B) Membrane potential of paternal mitochondria in early embryos. 
Embryos, generated by mating wildtype females with PhAM males, were collected 
at 12 hours after fertilization and cultured in vitro. At 18, 48, or 72 hours after 
fertilization, the embryos were incubated in 20 nM TMRE, washed, and imaged by 
fluorescent microscopy. Dashed box indicates region enlarged below. Arrows 
indicate examples of mito-Dendra2 positive spots lacking TMRE signal. Scale bar, 
10 μm. (C) Fluorescence line analysis of the boxed regions in (A and B). Each plot 
measures the TMRE and mito-Dendra2 signals along a one-pixel width line through 
the center of the boxed region. Note that the mito-Dendra2 and TMRE signals are 
co-incident at 18 hours after fertilization but not at 48 or 72 hours.  
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Figure 2.1 
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Figure 2.2 
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Figure 2.3 
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Figure 2.4 
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Figure 2.S1 
 
 
 
 115 
Figure 2.S2 
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Figure 2.S3 
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Figure 2.S4 
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ABSTRACT 
In addition to regulating mitochondrial morphology, mitochondrial fusion 
protects mitochondrial function, facilitating content mixing between mitochondria, 
including proteins, lipids, and mitochondrial DNA (mtDNA). Cells lacking 
mitochondrial fusion due to deletion of the mitochondrial GTPases, MFN1 and 
MFN2 (MFN-null cells) exhibit severe mitochondrial dysfunction, and 
heterogeneity of mtDNA, membrane potential, and proteins. Here we examine 
mitophagy in MFN-null cells. We find a high level of mitophagy in these cells that 
is dependent on the autophagy adaptor, p62 and independent of the structurally 
similar adaptor, NBR1. We show that p62 localizes to a subset of mitochondria that 
are depolarized and lack mtDNA, and that this localization is independent of the 
ubiquitin-binding domain of p62. Our results confirm a role for p62 in mitophagy, 
and suggest a novel ubiquitin-independent mechanism for its recruitment to 
mitochondria.   
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INTRODUCTION 
Mitochondria are dynamic organelles that fuse and divide to maintain the 
functional status of the population (Detmer and Chan, 2007; Hoppins et al., 2007). 
In mammalian cells, three large dynamin-like GTPase proteins conduct 
coordinated fusion of the outer and inner mitochondrial membranes (OMM and 
IMM). In mammals, the early steps in membrane fusion involve the OMM 
resident proteins, mitofusin 1 (MFN1), and mitofusin 2 (MFN2) (Koshiba et al., 
2004; Meeusen et al., 2004). The IMM protein, optic atrophy 1 (OPA1) is 
essential for IMM fusion (Meeusen et al., 2006; Song et al., 2009). Mitochondrial 
fusion is the key process underlying mitochondrial morphology (Chen et al., 
2003); however, it also plays a role in maintaining mitochondrial function and 
mtDNA stability, and is thought to protect the functional status of the 
mitochondrial population by facilitating content mixing amongst mitochondria 
(Chen et al., 2007; Chen et al., 2010; Detmer and Chan, 2007).   
Cells that lack mitochondrial fusion due to loss of MFN1 and MFN2 
(MFN-null) have fragmented mitochondria as well as severe defects in respiratory 
capacity, cell growth rate, and mitochondrial membrane potential (ΔΨm) (Chen et 
al., 2005). In these cells, the fragmented mitochondria become functionally 
heterogeneous, with widely divergent ΔΨm, protein levels, and mtDNA levels and 
mutation load. This dysfunction has severe consequences for the organism. In 
mice, loss of mitochondrial fusion in skeletal muscle results in a lethal 
mitochondrial myopathy (Chen et al., 2010). 
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The fate of these dysfunctional mitochondria in MFN-null cells is 
unknown, however some evidence suggests that mitophagy may be involved in 
their removal (Narendra et al., 2008). Mitophagy is specialized form of 
macroautophagy, an intracellular degradation system mediated by the 
autophagosome and the lysosome. Mitochondria that are targeted for degradation 
are engulfed by a double-membrane vesicle called the isolation membrane or 
autophagophore, which ultimately fuses with the lysosome. The lysosomal low 
pH and hydrolase activity cooperate to degrade the autophagosomal inner 
membrane and contents (Nakamura et al., 1997).  Specificity of this process is 
believed to be achieved by the recruitment of autophagy receptors, which are 
selective for specific cargoes (Johansen and Lamark, 2011).  
Among the currently identified autophagy receptors are the structurally 
similar proteins, sequestosome 1 (SQSTM1) or p62 (hereafter referred to as p62), 
and neighbor of BRCA1 gene 1 (NBR1) (Geisler et al., 2010; Kirkin et al., 2009). 
Both were found to localize to the isolation membrane (Itakura and Mizushima, 
2011a), and both contain at least four key domains.  
The N-terminal PB1 domain mediates homo- and hetero-dimerization 
(Lamark et al., 2003). In vivo studies suggest that oligomerization of p62 is 
required for its association with cargo and for delivery to the autophagosome 
(Bjorkoy et al., 2005; Ichimura et al., 2008a; Itakura and Mizushima, 2011b), as 
well as for activation of the oxidative stress response regulation transcription 
factor NRF2 (Jain et al., 2010; Komatsu et al., 2010a).  
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Both p62 and NBR1 contain ZZ-type zinc finger domains. Their function 
is yet unknown; however, some evidence suggests that they may modulate 
protein-protein interactions (Lin et al., 2013).  
Like most autophagy receptors, p62 and NBR1 contain LC3 binding 
motifs called LC3-interacting regions (LIR). P62 contains one LIR domain in the 
C-terminal half of the protein, whereas NBR1 contains two LIR domains with a 
coiled coil domain between them (Ichimura et al., 2008b; Noda et al., 2010; 
Pankiv et al., 2007). In mammalian cells, LC3 is present on both the outer and the 
inner membrane of the autophagosome, and it is generally thought that binding of 
receptors to LC3 may allow their cargo to be selectively engulfed by 
autophagosomes (Kirkin et al., 2009; Lamark et al., 2009), however LC3 
independent mechanisms may exist (Cao et al., 2008). Of note, p62 localization to 
the isolation membrane was found to be independent of LC3 but dependent 
instead on self-oligomerization, suggesting that a simple LC3 focused model for 
cargo delivery to autophagosomes is incomplete (Itakura and Mizushima, 2011b).  
Finally, the C-terminus of both p62 and NBR1 contains an ubiquitin 
association domain (UBA) (Long et al., 2010). This domain is commonly 
believed to be the means of cargo recognition by receptor proteins. The UBA 
domain of p62 preferentially interacts with K63-linked poly-ubiquitin chains, 
whereas the UBA domain of NBR1 shows less linkage preference (Geisler et al., 
2010). The interaction of p62 with ubiquitin is modulated by phosphorylation of 
the UBA domain (Matsumoto et al., 2011). Ubiquitination of OMM proteins such 
as the mitofusins, or VDAC1 could be a mitophagy signal recognized by p62 
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(Sarraf et al., 2013). This ubiquitination is induced by loss of mitochondrial 
membrane potential (ΔΨm) and mediated by E3 ligases such as parkin RBR E3 
ubiquitin protein ligase (PARKIN), mitochondrial ubiquitin ligase activator of 
NK-kB (MUL1), or ring finger protein 185 (RNF185) (Youle and Narendra, 
2011; Yun et al., 2014a). Through an elegant ΔΨm sensing mechanism, PARKIN  
is recruited specifically to depolarized mitochondria. In MFN-null cells a subset 
of mitochondria have low ΔΨm, and Narendra et al. reported selective 
accumulation of PARKIN on these mitochondria (Narendra et al., 2008). 
However, whether the UBA is essential for the function of p62 in autophagy 
generally and whether p62 is involved in MFN-null cells is unknown. 
Roles for p62 and NBR1 in mitophagy have been suggested, but remain 
unclear. P62 was shown to colocalize with some mitochondria under basal 
conditions (Seibenhener et al., 2013b), and we have previously shown localization 
of p62 to mitochondria in mitophagy-inducing conditions (unpublished). 
Although work by Geisler et al. suggested that p62 may be essential for 
mitophagy, Narendra et al. suggested that it may only be required for 
mitochondrial clustering and not degradation (Geisler et al., 2010; Narendra et al., 
2010a). NBR1 has been implicated in autophagic degradation of ubiquitinated 
substrates (Kirkin et al., 2009), and pexophagy specifically (Deosaran et al., 
2013), and it has been proposed as a candidate mitophagy adaptor. Chan et al. 
found NBR1 in a screen of the mitochondrial proteome in HeLa cells undergoing 
CCCP-induced mitophagy (Chan et al., 2011). Shi et al. found the same by 
immunofluorescence, but further characterization of the functional role of NBR1 
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indicated that it may be dispensable for mitophagy under this condition (Shi et al., 
2015). Thus, how and why p62 and NBR1 localize to mitochondria during 
mitophagy and what role they may play are open questions.  
In this study, we investigate the roles of p62 and NBR1 in steady-state 
mitophagy in MFN-null MEFs. We find that NBR1 is dispensable for this 
process, and demonstrate that p62 is preferentially targeted to the subset of 
depolarized mitochondria that lack mtDNA, and that it is essential for their 
ubiquitination and delivery to lysosomes. Finally, we examine how p62 is 
recruited to mitochondria and find that the oligomerization or LC3 binding 
regions are independently sufficient to localize p62 to a subset of mitochondria, 
but that this localization is independent of the ubiquitin binding region of p62.  
  
 
 131 
RESULTS 
P62 is necessary for maintaining ΔΨm in the absence of mitofusins 
We performed stable isotope labeling by amino acids in cell culture 
(SILAC) analysis (Ong et al., 2002) to monitor changes in the mitochondrial 
proteome in mouse embryonic fibroblast (MEF) cells defective in mitochondrial 
fusion due to complete knock-out of mitofusins, Mfn1 and Mfn2 (MFN-null). By 
this approach, we quantified 2532 unique protein groups. Of these, 756 were 
mapped to proteins in the mouse MitoCarta database (Calvo et al., 2016), which 
contains 1158 mitochondrial proteins. This represents a 65 percent coverage of 
the mitochondrial proteome, which is highly comprehensive, given that fewer 
mitochondrial proteins are expressed in cultured cells than in tissues (Duborjal et 
al., 2002). 
To sort through the proteins enriched on mitochondria in MFN-null cells, 
we considered only those with a calculated significance of <0.01 (Table 3.1). 
Amongst the top nine proteins enriched in MFN-null cells, six are involved in 
metabolism, and one is involved in mtDNA transcription. This is not surprising 
given that mitochondria from MFN-null cells are dysfunctional, with defective 
respiratory activity due to mtDNA loss and resulting Complex I deficiency (Chen 
et al., 2010). Of the remaining two proteins, one is a resident of the ER involved 
in ER stress response. This is not surprising, as ER-mitochondrial contacts are 
well established, and loss of MFN2 has been shown to increase the number of 
such contact points (Filadi et al., 2015). Finally, the autophagy adaptor/receptor 
protein, p62/SQSTM1 is increased six-fold on MFN-null mitochondria. 
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Mitochondrial localization of p62/SQSTM1 has been observed before 
(Seibenhener et al., 2013b); however, its enrichment on mitochondria in the 
absence of mitofusins has never been reported.  
To confirm that p62, which is normally a cytosolic protein, localizes to 
mitochondria in MFN-null cells, we collected whole cell lysate or isolated 
mitochondria from wildtype and MFN-null cells, and probed for p62 by western 
blot (Figure 3.1A). Consistent with our SILAC results, we found that p62 is 
selectively enriched on mitochondria of MFN-null cells, but we detected no such 
enrichment in whole cell lysate from MFN-null cells, suggesting that p62 is 
recruited specifically to mitochondria. To further characterize the localization of 
p62, we immunostained wildtype and MFN-null cells for p62 and HSP60 (Figure 
3.1C). MFN-null cells showed an overall increase in the abundance of p62, as 
well as an increase in the colocalization of p62 with mitochondria relative to 
wildtype cells, suggesting that p62 specifically localizes to mitochondria in the 
absence of mitochondrial fusion. 
Interestingly, we found that p62 only localizes to a subset of on MFN-null 
mitochondria (Figure 3.1C). This finding is in contrast to what we previously 
reported for wildtype MEFs, in which mitophagy stimulation causes p62 
localization to all mitochondria. Previous studies have demonstrated that MFN-
null cells have dysfunctional mitochondria with heterogeneity of ΔΨm (Chen et 
al., 2005; Chen et al., 2003). We wondered whether the increased p62 on MFN-
null mitochondria might help maintain functional status of the mitochondrial 
population by targeting mitochondria with reduced ΔΨm for degradation. If this 
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were true, loss of p62 in MFN-null cells would result in a reduction in the average 
ΔΨm measured over all mitochondria in a cell. To test the dependence of 
membrane potential on p62, we first transduced MFN-null cells with one of two 
shRNAs targeting p62 (Figure 3.1B). The second of these shRNAs (sh2) reduced 
the level of p62 by 97%, and was used in all following experiments. To measure 
ΔΨm, wildtype and MFN-null cells were stained with the cyanine dye, JC-1 
(5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolocarbo-cyanine iodide) 
(Reers et al., 1991; Smiley et al., 1991). JC-1 exists in either a monomeric or 
aggregated form. So called, J-aggregates, form at the high concentration reached 
inside of highly active mitochondria (those with high ΔΨm). When excited at 488 
nm JC-1 monomers emit green fluorescence with a maximum at 530 nm, whereas 
J-aggregates emit orange-red fluorescence with a maximum at 595 nm. Therefore, 
mean fluorescence intensity of J-aggregates per cell represents average ΔΨm of 
the mitochondrial population, whereas total fluorescence intensity of JC-1 
monomer indicates total mitochondrial mass. Cells were imaged by confocal 
microscopy and mean fluorescence intensity per cell was measured (Figure 3.1D). 
Consistent with previous studies (Seibenhener et al., 2013b) we found that loss of 
p62 results in a 40 to 60 percent reduction in overall ΔΨm in MFN-null cells 
(Figure 3.1E). Total mitochondrial mass, as indicated by JC-1 monomer 
fluorescence, was relatively unchanged by loss of p62 (Figure 3.1E), suggesting 
that p62 is required for maintenance of ΔΨm. 
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P62 is required for degradation of a subset of defective mitochondria by 
mitophagy in MFN-null cells.  
Previous studies have shown that MFN-null cells have lower levels of 
mtDNA than wildtype cells (Chen et al., 2010). Mitochondria lacking mtDNA are 
unable to perform normal respiration because of a lack of key OXPHOS complex 
subunits. We wondered, therefore, whether the subset of mitochondria labeled 
with p62 contained mtDNA. We performed immunofluorescence staining of 
MFN-null cells with anti DNA and anti p62 antibodies (Figure 3.2A). Although 
many mitochondria that lacked mtDNA did not show p62 colocalization, p62 was 
never found to colocalize with mitochondria that contained mtDNA. Furthermore, 
p62 labeled mitochondria exhibited weaker Mitotracker Red staining than other 
mitochondria. Mitotracker Red accumulates in mitochondria in a ΔΨm dependent 
manner (Perry et al., 2011), so this staining pattern indicates that p62 positive 
mitochondria have low ΔΨm. Taken together, these results are consistent with the 
idea that p62 localizes preferentially to dysfunctional mitochondria.  
Previous studies have shown that p62 plays a role in maintenance of 
mitochondrial genome integrity in both mice and cultured cells. Overexpression 
of P62, even in wildtype cells, increases the levels of mtDNA (Seibenhener et al., 
2013b). An alternate explanation, therefore, for the association of p62 with a 
subset of mitochondria apparently lacking mtDNA is that p62 promotes mtDNA 
replication in these mitochondria to restore mtDNA to detectable levels. If this 
were true, loss of p62 in MFN-null cells would reduce the total amount of 
mtDNA per cell, and increase the fraction of mitochondria lacking mtDNA. To 
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measure this we imaged cells labeled with the double-stranded DNA dye, 
PicoGreen, as well as the mitochondria-specific dye, Mitotracker Red-FM, and 
quantified the percent of mitochondria colocalizing with DNA stain (Figure 
3.2B). To measure mtDNA content, we performed quantitative PCR on DNA 
from MFN-null cells with and without p62 shRNA (Figure 3.2C). We found that 
knockdown of p62 had no effect on the fraction of mitochondria lacking mtDNA 
(Figure 3.2B), or the amount of mtDNA (Figure 3.2C), suggesting that the role of 
p62 in MFN-null cells is not in mtDNA maintenance.  
P62 is a known autophagy receptor (Johansen and Lamark, 2011), and 
more recently it has been implicated in mitophagy (Geisler et al., 2010; Narendra 
et al., 2010a). We previously reported that p62 is essential for mitophagy under 
OXPHOS-inducing growth conditions in MEF cells and that MFN-null cells have 
increased levels of mitophagy (Chapter 2). To test whether p62 is required for 
steady-state mitophagy in MFN-null cells, we utilized a dual-color fluorescence-
quenching assay with a mitochondrially localized EGFP-mCherry reporter. When 
this construct is expressed, normal mitochondria are yellow, with both GFP and 
mCherry fluorescence visible in the matrix, whereas when mitochondria are in 
acidic compartments, such as the autolysosome, only mCherry fluorescence is 
intact, due to the selective sensitivity of EGFP fluorescence to low pH. We 
assayed mitophagy in MFN-null cells, MFN-null cells with p62 shRNA, and also 
MFN-null p62 knockdown cells with exogenous p62-Turquoise expression. 
Whereas close to 90% of control cells exhibit many red puncta constitutively, in 
p62 shRNA expressing cells red puncta are strongly reduced. Less than 20% of 
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cells showed red puncta.  When p62 knockdown cells also expressed exogenous 
p62, the red puncta were restored (Figure 3.2D,E). To confirm that the red 
mitochondrial puncta observed in MFN-null cells at steady-state are in 
autophagosomes, we expressed an mTurquoise2 tagged version of LC3B, and 
imaged cells with and without p62 shRNA. We found that LC3B colocalizes with 
the red puncta, suggesting that they do represent mitochondria in autophagosomes 
(Figure 3.2E). Taken together, these results are consistent with a requirement for 
p62 in steady-state mitophagy of MFN-null mitochondria.  
  
The PB1 and LIR domains but not the UBA of p62 are sufficient for its 
localization to mitochondria. 
P62 contains four key domains and several binding motifs. The N-terminal 
PB1 domain mediates homo- and hetero-dimerization (Lamark et al., 2003). The 
ZZ-type zinc finger may modulate protein interactions, but is yet of unknown 
function (Lin et al., 2013). The LC3 interacting region (LIR) associates with the 
core autophagosomal protein, LC3 (Ichimura et al., 2008b; Pankiv et al., 2007), 
and the C-terminal UBA domain binds ubiquitinated substrates (Long et al., 
2010). P62 is considered an autophagy receptor because it can recognize 
ubiquitinated proteins via its UBA domain, and link them to the autophagosome 
via its interaction with LC3; however, this function has not been proven with 
respect to mitochondria. We sought to determine how p62 localizes to 
mitochondria, whether by binding ubiquitinated proteins, or by some other 
method. First, we expressed a full-length mTurquoise2-p62 fusion protein in 
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MFN-null cells expressing the mitophagy marker, cox8-EGFP-mCherry. Similar 
to our observations by immunostaining, we again found that p62 localizes to only 
a subset of mitochondria in MFN-null MEFs, and interestingly, this subset 
consists exclusively of the red mitochondria that are undergoing mitophagy 
(Figure 3.3A).  We next tested a series of truncated versions of p62 for 
localization to mitochondria (Figure 3.3B). Given that we observed p62 
localization to acidic compartments in which GFP fluorescence is not detectable, 
we chose the acid-stable fluorescent proteins, mCherry and mTurquoise2 for our 
analysis. We co-expressed mCherry-tagged p62 constructs with mitochondrially 
targeted mTurquoise2 and imaged by confocal microscopy.  As observed 
previously, full-length p62-mCherry (p62-Full) localizes to a subset of 
mTurquoise2 positive mitochondria. Interestingly, this localization pattern is 
recapitulated by the N-terminal half of p62 containing only the PB1 and ZZ 
domains, and lacking the LIR and UBA domains, and is maintained even when 
only the PB1 domain of p62 is expressed, without the ZZ domain. When the ZZ 
domain is expressed by itself, it is diffusely cytosolic with no obvious localization 
to mitochondria, suggesting that the PB1 domain alone is sufficient to localize 
p62 to mitochondria. This is consistent with previous work by Itakura and 
Mizushima who observed the same phenomenon with respect to p62 localization 
to the autophagosome formation site (Itakura and Mizushima, 2011b). The C-
terminal half of p62 contains both the LIR and UBA domains, the two domains 
thought to be important in an autophagy adaptor. However, we found that the C-
terminal half of p62 is predominantly cytosolic, with some localization to 
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mitochondria. This colocalization may be due to LIR domain interaction with 
autophagosomes, as the LIR domain alone produces the same localization pattern 
as the full C-terminus, whereas the UBA domain, alone, does not. This is 
surprising, given that ubiquitination of mitochondria often precedes mitophagy 
(Narendra et al., 2010b), and it is assumed that autophagy adaptors localize to 
their substrates via ubiquitin binding. The PB1 domain of p62 is a multifunctional 
domain that enables interaction with a variety of proteins, including dimerization 
and oligomerization of p62 itself (Lamark et al., 2003; Wilson et al., 2003). One 
possible explanation for the PB1 domain fragment localizing to mitochondria is 
that it can interact with endogenous p62 present in MFN-null cells.  To address 
this issue, we expressed the PB1-mCherry construct in p62 knockout MEFs 
grown under OXPHOS-inducing conditions, which has been previously shown to 
induce mitophagy (Figure 3.3C) (Melser et al., 2013). In these cells, the PB1-
mCherry construct also localizes to punctate mitochondria as in MFN-null cells 
under basal conditions, suggesting that the PB1 domain alone in the absence of 
endogenous p62 is sufficient to localize to mitochondria. 
 
Ubiquitination of MFN-null mitochondria is dependent on p62 
The observation that the UBA domain of p62 is neither necessary nor 
sufficient to localize p62 to mitochondria is surprising. We have previously 
shown that cells with high levels of mitophagy have mitochondria that are highly 
ubiquitinated (Chapter 2). We wondered, therefore, if the function or localization 
of p62 on mitochondria in MFN-null cells occurs upstream of ubiquitination. To 
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test this we isolated mitochondria from MFN-null cells with or without p62 
shRNA and probed for ubiquitin by western blot. We found that the level of 
ubiquitin on MFN-null cells is decreased when p62 is knocked-down with either 
of two shRNAs (Figure 3.4A), consistent with a role for p62 upstream of 
ubiquitination of mitochondria.  
To further test a possible interaction of the UBA domain of p62 with 
ubiquitinated mitochondria, we first measured mitophagy levels in MFN-null 
MEFs expressing the cytosolic UBA domain of p62. If p62 binding to 
mitochondria via its UBA domain is required for mitophagy, this construct may 
interfere with mitophagy in a dominant negative fashion, by impeding the binding 
of endogenous, full-length p62. The level of mitophagy in UBA expressing MFN-
null cells was mildly reduced relative to control cells (Figure 3.4 B), suggesting a 
possible role for ubiquitin in facilitating mitophagy in MFN-null cells, and 
confirming that the UBA domain can act in a dominant negative fashion. 
However, the reduction we saw due to UBA expression was far less complete 
than when p62 was knocked down by shRNA, suggesting that ubiquitin binding 
cannot be the only mechanism for p62 function in mitophagy. 
We also tested a role for the UBA domain in mitophagy of sperm 
mitochondria in the embryo. We retrovirally expressed UBA-mCherry in pre-
implantation mouse embryos fertilized with sperm expressing the green 
fluorescent protein, Dendra, targeted to mitochondria. Mouse sperm mitochondria 
are ubiquitinated prior to fertilization (Sutovsky et al., 2000), and we have 
previously shown that p62 is involved in their degradation. If p62 binding to 
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ubiquitin on sperm mitochondria is an essential step in mitophagy, expression of 
the UBA domain of p62 might act as a dominant negative and interfere with the 
function of endogenous p62. We found, however, that the UBA domain had no 
effect on the degradation of paternal mitochondria, which proceeded normally 
such that all paternal mitochondria were degraded in UBA injected and control 
embryos by 84 hours after fertilization (Figure 3.4C,D). This result may either 
indicate that the p62 UBA domain does not act as a dominant negative in 
embryos, or it may suggest that the ubiquitin binding by p62 is not important for 
mitophagy of paternal mitochondria in embryos. Our observation of a decreased 
effect of the UBA in embryos relative to MEFs may be due to the higher 
sensitivity of the cell-culture assay. Taken together, these results suggest that p62 
may have some function on mitochondria that is upstream of mitochondrial 
ubiquitination. 
 
P62 homolog, Nbr1 is not required for mitophagy in MFN-null MEFs or 
embryos 
Like p62, another structurally similar protein, neighbor of BRCA1 gene 1 
(NBR1), is also selectively degraded by autophagy (Kirkin et al., 2009). NBR1 
has been implicated in pexophagy (Deosaran et al., 2013), and was identified in a 
proteomic analysis of mitochondria undergoing CCCP-induced mitophagy (Chan 
et al., 2011). However, recent work suggests that its role in CCCP-induced 
mitophagy, if any, may be dispensable (Shi et al., 2015). We tested whether Nbr1 
might be involved in steady-state MFN-null mitophagy using our mitophagy 
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marker in MFN-null cells with or without knockdown of NBR1. Consistent with 
Shi et al., we found that NBR1 knockdown had no effect on the percent of MFN-
null cells undergoing steady-state mitophagy (Figure 3.5A). 
We next examined the role of NBR1 in mitophagy in embryos. We 
retrovirally expressed shRNA against NBR1 in preimplantation embryos with 
fluorescent paternal mitochondria, and assessed the presence or absence of 
paternal mitochondria at 84 hours after fertilization. Consistent with our MFN-
null results, we found that knockdown of NBR1 did not inhibit degradation of 
paternal mitochondria in the embryo (Figure 3.5B,C). In contrast, knockdown of 
p62 strongly inhibited degradation of paternal mitochondria, with the majority of 
embryos retaining more than five clusters of Dendra-positive paternal 
mitochondria at 84 hours post fertilization. Due to their structural similarity, p62 
and NBR1 may have redundant functions, which may mask an effect of NBR1 in 
the presence of p62. Therefore, we assessed the effect of NBR1 knockdown with 
concurrent knockdown of p62. We found no difference in degradation of paternal 
mitochondria between knockdown of p62 alone, or knockdown of NBR1 and p62 
together, suggesting that NBR1 is dispensable for mitophagy of paternal 
mitochondria in the presence or absence of p62.     
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DISCUSSION 
Mitochondrial fusion is a protective process that increases respiration, 
safeguards mtDNA, and maintains ΔΨm. The heterogeneous mitochondrial 
dysfunction in cells deficient in mitochondrial fusion has been shown to be 
damaging to the organism (Chen et al., 2010); however, the mechanisms by which 
MFN-null cells cope with this state are unclear. Previous evidence suggests that 
the PARKIN mediated mitophagy pathway may be involved in clearing damaged 
mitochondria from MFN-null cells (Narendra et al., 2008). Here we investigate 
the role of mitophagy receptor proteins in this process, providing further evidence 
for preferential targeting of defective mitochondria by the mitophagy machinery, 
and linking mitophagy to mitochondrial dynamics.  
Several lines of evidence suggest an intimate link between mitochondrial 
dynamics and mitophagy. Mitochondrial fusion has been shown to be a selective 
process. Mitochondria with intact ΔΨm fuse preferentially with mitochondria of 
similar ΔΨm, generating a sub-population of dysfunctional mitochondria, and 
conversely, mitochondrial fission generates metabolically uneven daughters 
(Twig et al., 2008). Mitochondrial depolarization results in Parkin accumulation 
and can trigger mitophagy (Narendra et al., 2008). OPA1 overexpression, on the 
other hand, decreases mitophagy, presumably by activating fusion (Twig et al., 
2008). Using a fluorescence-quenching assay we show that cells lacking 
mitochondrial fusion exhibit a high level of steady-state mitophagy (Figure 
3.2D,E), confirming the downstream result of the PARKIN accumulation 
observed by Narendra et al.  
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Our results suggest that p62 may play a key role in maintaining the 
functional status of the mitochondrial population in cells lacking mitochondrial 
fusion. We find that p62 supports the maintenance of ΔΨm of the mitochondrial 
population in MFN-null cells (Figure 3.1D,E), and that it is recruited to a subset 
of mitochondria that are depolarized and lack mtDNA, potentially priming them 
for clearance from the cell (Figure 3.2A).  
We show a requirement for p62 in steady-state mitophagy in MFN-null 
cells (Figure 3.2D,E) that is novel. The requirement for p62 at steady-state may 
explain the phenotypes observed due to loss of p62 in wild-type cells including 
mitochondrial fragmentation, loss of mtDNA, and depolarization of mitochondria 
(Seibenhener et al., 2013b). Loss of p62 may impair basal mitochondrial quality 
control, and although fewer mitochondria may be damaged at any given time in 
wildtype cells, over time damaged mitochondria, which are prevented from fusing 
with healthy mitochondria, could accumulate leading to an increasingly 
fragmented, dysfunctional population.  
Given the finding that p62 is required for mitophagy, it is surprising that 
we find no change in mitochondrial mass in the absence of p62 (Figure 3.1D). 
Given that our experiments utilize cells stably expressing p62 shRNA, it is 
possible that compensatory mechanisms are engaged in these cells to restore 
mitochondrial mass to baseline. It might be interesting to determine how acute 
verses chronic loss of p62 influences mitochondrial biosynthesis. How the 
mitophagy and biosynthetic machinery may interact is unknown. 
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There are many gaps in our knowledge of the signaling events during 
mitochondrial dysfunction leading to mitophagy. The mechanism by which p62 is 
targeted to mitochondria is one such unknown. It has been speculated that 
autophagy receptors are recruited to cargo through interaction with ubiquitin, 
however two of our findings contradict this model. First, sufficiency of the PB1 
domain (Figure 3.3B), which does not bind ubiquitin to localize p62 to 
mitochondria argues against an important role for ubiquitin upstream of p62 
recruitment to mitochondria. Secondly, the reduction in ubiquitination of 
mitochondria that we observed in MFN-null cells with p62 knockdown, suggests 
that p62 plays a role in mitophagy of MFN-null mitochondria upstream of 
ubiquitination of mitochondria (Figure 3.4A). This is a surprising finding given 
the traditional model for p62 function as an autophagy receptor that binds 
specifically to ubiquitinated substrates. One possibility is that p62 collaborates 
with an E3 ligase to ubiquitinate mitochondria, or, given that p62 is also known 
for its ability to form higher order complexes, that it forms a scaffold that recruits 
E3 ligases themselves, or other regulatory proteins. These mechanisms, however, 
are unprecedented. Furthermore, our results do not rule out possible ubiquitination 
of mitochondria prior to p62 binding. We also find that overexpression of the p62 
UBA domain has some limited effect on mitophagy in MFN-null cells (Figure 
3.4B), which is consistent with a role for ubiquitin in mitophagy in these cells. 
Interestingly, exogenous expression of the UBA domain has no effect on 
mitophagy in embryos (Figure 3.4C,D), consistent with a model in which the 
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function of p62 on mitochondria is independent of ubiquitin binding in that 
context.   
Surprisingly, we found not just one, but two domains capable of localizing 
p62 to mitochondria. The LIR domain of p62 also co-localizes with a 
subpopulation of mitochondria. Interestingly, these mitochondria are located 
primarily in the periphery of the cell, consistent with the site of autophagosome 
formation (Jahreiss et al., 2008). One possible explanation for this dual targeting 
is that the PB1 domain is the primary domain responsible for p62 binding to 
mitochondria, whereas the LIR domain co-localization is due to its interaction 
with the LC3 on autophagosomes that already contain mitochondria. This model 
would be consistent with previous observations that the direct interaction of LC3 
with p62 is not sufficient for efficient p62 degradation by autophagy (Ichimura et 
al., 2008b). Further investigation will be necessary to resolve this point.  
The localization of p62 to a subpopulation of mitochondria that we 
observed in MFN-null cells (Figure 3.3A), while consistent with previous studies 
defining the heterogeneity of mitochondria in these cells (Chen et al., 2005) is in 
contrast to our observations in wildtype cells undergoing OXPHOS-induced 
mitophagy, where p62 localizes to all mitochondria (Chapter 2). This may point to 
a key difference in the signaling mechanisms that trigger autophagy in these two 
cases, a topic that is currently unexplored. In MFN-null cells, mitophagy occurs at 
steady state, and appears to be the result of sequestration of a subset of defective 
mitochondria. In OXPHOS-induced mitophagy, or in CCCP-induced mitophagy 
(where the localization of p62 to mitochondria has not been explored), the entire 
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mitochondrial population is equally subjected to the change in cellular conditions 
and needs to respond. In contrast to these metabolically or pharmacologically 
induced mitophagy systems, basal mitophagy levels in wildtype cells are believed 
to be very low and highly tissue specific (Katayama et al., 2011; Sun et al.). 
Mitophagy in MFN-null cells may better replicate basal mitophagy but at an 
amplified scale, since more mitochondria are dysfunctional at any given time. 
This may make MFN-null cells a tractable model system in which to study 
steady-state mitophagy, a phenomenon which has thus far been difficult to 
address.  
In particular, the signaling mechanism that may be involved in p62 
accumulation on different populations of mitochondria is currently unknown, 
although several well-characterized signaling cascades are candidates. P62 
interacts with the transcription factor NRF2, stabilizing it, and thereby activating 
NRF2 target genes (Komatsu et al., 2010b). NRF2 is one of the main cellular 
defense mechanisms combatting oxidative stress (Itoh et al., 1997). This pathway 
could be involved in the signaling of either steady state or OXPHOS-induced 
mitophagy. Furthermore, the PB1 domain of p62 is known to interact with 
atypical protein kinase C (PKC) family members (Sanchez et al., 1998). The PKC 
pathway kinases have a breadth of tissue-specific effects, which are unexplored in 
relation to mitophagy. Furthermore, p62 has recently been shown to bind to 
Raptor, an integral part of the mTORC1 complex which senses nutrients (Duran 
et al., 2011). Recent evidence suggests that the mTORC1 pathway may interface 
with mitophagy (Gilkerson et al., 2012).  
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Further evidence for the specificity of the signaling upstream of p62 
recruitment is our observation that NBR1, a protein that is very structurally 
similar to p62 and known to localize to mitochondria, is not required for 
mitophagy in MFN-null cells or embryos irrespective of the presence of p62 
(Figure 3.5A-C). This is consistent with experiments in Parkin expressing 
wildtype cells treated with CCCP (Shi et al., 2015). This does not rule out a non-
essential role for NBR1 in mitophagy, which could still be recruited to 
mitochondria via hetero-dimerization of its PB1 domain with that on p62.  
One possible explanation for the preferential requirement for p62 over 
NBR1 could be a specific p62 binding partner on mitochondria. A candidate for 
this role might be TBC1D15, which is recruited to mitochondria by its binding 
partner, FIS1, and implicated in mitophagy (Yamano et al., 2014). We found an 
interaction between p62 and TBC1D15 by co-immunoprecipitation and mass spec 
analysis of p62 binding partners on MFN-null mitochondria (unpublished data). 
Some evidence suggests that high levels of exogenous FIS1 can drive mitophagy 
(Gomes and Scorrano, 2008), but whether endogenous FIS1 and TBC1D15 levels 
are increased specifically on dysfunctional mitochondria is currently unknown.  
In summary, our data reinforce the link between mitochondrial dynamics 
and mitophagy. We identify p62 as a key player in steady-state mitophagy in 
MFN-null cells, and rule out Nbr1 as an essential mitophagy receptor in this 
context. We propose that p62 plays a role in mitophagy upstream of 
ubiquitination of mitochondria, and may instead be recruited by specific protein-
protein interactions. Because of its specificity for a subpopulation of 
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mitochondria, mitophagy in MFN-null MEFs may be a tractable model system for 
the low level of steady-state mitophagy ongoing in wildtype cells. 
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MATERIALS AND METHODS 
Cell lines  
The cells used included: p62-null MEFs (Ichimura et al., 2008b) (kindly 
provided by Shun Kageyama and Masaaki Komatsu), MFN-null, and wildtype 
MEFs have been described previously (Chen et al., 2005). 
 
Cell culture 
MEFs were maintained in Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin 
and 100 U/mL streptomycin at 37°C and 5% CO2. Acetoacetate containing media 
was made as previously described (Mishra et al., 2014). For mitophagy 
experiments, cells were plated on Nunc Lab-Tek II Chambered Coverglass slides 
(155409, Thermo) in DMEM-based media. MFN-null cells were imaged in this 
media one day after plating. P62 knockout MEFs were treated as follows: after 
cells had adhered, they were washed with PBS and acetoacetate-containing 
medium was applied, after which cells were allowed to grow for four days and 
then imaged.  
 
Stable isotope labeling by amino acid in cell culture (SILAC) 
SILAC, including isotope labeling, mitochondrial isolation and 
purification, isoelectric focusing of peptides, and mass spectrometric analysis, 
was performed as described in (Chan et al., 2011). Wildtype cells were passaged 
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ten-times in heavy medium before analysis. MFN-null cells were passaged in 
regular medium.  
 
Isolation of mitochondria 
For immunoblot analysis, mitochondria were isolated as previously 
described (Pagliarini et al., 2008). For SILAC, mitochondria were isolated as 
described in (Chan et al., 2011)  
 
Data analysis 
Raw data files were analyzed as described in (Chan et al., 2011) except 
that the IPI mouse database (v 3.54) was searched. Protein groups significantly 
different overall ratios (P < 0.01) and with significantly different ratios in both 
replicates (P < 0.05) were considered to be significantly altered. Mitochondrial 
annotations were derived from MitoCarta (Pagliarini et al., 2008). 
 
Antibodies and reagents 
The following commercially available antibodies were used: anti-Hsp60 
(SC-1054, Santa Cruz Biotech), anti-P62 (PM045, MBL), anti-VDAC1 (4661S, 
Cell Signaling), anti-DNA (CBL186, Chemicon), and anti-Ubiquitin (P4D1, Cell 
Signaling). The following commercially available dyes were used: JC-1 dye 
(T3168, ThermoFisher), PicoGreen (P7581, Invitrogen), and MitoTracker Red 
FM (M22425, Invitrogen). 
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Immunostaining 
For immunofluorescence experiments, cells were fixed with 10% 
formalin, permeabilized with 0.1% Triton X-100, and stained with the primary 
antibodies listed above and with the following secondary antibodies: goat anti-
mouse Alexa Fluor 488, donkey anti-goat Alexa Fluor 546, goat anti-rabbit Alexa 
Fluor 488, and goat anti-rabbit Alexa Fluor 633 (Invitrogen). When used, DAPI 
(d1306, Invitrogen) was included in the last wash. 
 
shRNA virus design and production 
For experiments in MEFs, the retroviral vector pRetroX-H1, which 
contains the H1 promoter, was used to express shRNAs. shRNAs were cloned 
into the BglII/EcoRI sites. For embryo injection experiments, a third-generation 
lentiviral backbone was used to express shRNAs. The lentiviral vector FUGW-H1 
(Fasano et al., 2007) was modified by replacing the GFP reporter gene with 
mCherry and changing the shRNA cloning sites from Xba/SmaI to BamHI/EcoRI, 
generating FUChW-H1. For dual knockdown experiments in embryos, a second 
H1 promoter was added, along with XbaI/NheI cloning sites 3’ to the original H1 
promoter, generating FUChW-H1H1. 
The shRNA target sequences were: 
p62 sh2: TGGCCACTCTTTAGTGTTTGTGT 
p62 sh1: GACAACCCGTGTTTCCTTTATTA 
NBR1: GGAGTGGATTTACCAGTTATT 
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Non-targeting: GACTAGAAGGCACAGAGGG 
Lentiviral vectors were cotransfected into 293T cells with plasmids 
pMDLG/pRRE, pIVS-VSVG, and pRSV-Rev. Retroviral vectors were 
cotransfected into 293T cells with plasmids pVSVG and pUMVC. All 
transfections were done using calcium phosphate precipitation. For 
microinjection, virus was collected, filtered, concentrated by ultracentrifugation at 
25,000 rpm for 2 hours, resuspended in PBS, and stored at -80°C as described 
previously (30, 31). Viral titers were measured by infecting MEFs with serial 
dilutions of viral preparations, followed by flow cytometric analysis after 48 hr. 
Virus was used at 1x107 transducing units/μL. 
 
Embryo microinjection 
All mouse work was done according to protocols approved by the 
Institutional Animal Care and Use Committee at the California Institute of 
Technology. For each experiment, four C57/Bl6J wildtype female mice at 21-25 
days old were superovulated by hormone priming as described previously (Pease 
and Lois, 2006), and then each was caged with a PhAM male (Pham et al., 
2012b). After euthanization of females by CO2 asphyxiation, the embryos were 
harvested and placed in M2 medium (MR-015-D, Millipore) at 12 hours after 
fertilization as described in (Pease and Lois, 2006). Approximately 60 to 100 
embryos were collected per experiment. Embryos were divided into two equal 
groups and microinjected with 10 to 100 pl of viral stock into the perivitelline 
space as described in (Lois et al., 2002; Pease and Lois, 2006). Embryos were 
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washed with KSOM+AA medium (MR-106-D, Millipore) and cultured in that 
medium covered by oil (M8410, Sigma) at 37°C and 5% CO2. For each construct, 
at least three separate microinjection sessions were performed. In preparation for 
imaging, embryos were transferred to 10 μl droplets of KSOM+AA medium on 
glass-bottom dishes (FD35-100, World Precision Instruments). 
 
Imaging 
All images were acquired with a Zeiss LSM 710 confocal microscope with 
a Plan-Apochromat 63X/1.4 oil objective. All live imaging was performed in an 
incubated microscope stage at 37°C and 5% CO2. The 488 nm and 561 nm laser 
lines were used to excite cox8-EGFP-mCherry and imaging was done in line 
mode to minimize movement of mitochondria between acquisition of each 
channel. The 405 nm laser line was used to excite mTurquoise2 and DAPI. Alexa 
488 conjugated dyes, the monomeric form of JC-1, and picoGreen were excited 
by the 488 nm laser. Alexa 546 conjugated dyes, the J-aggregate form of JC-1, 
mCherry, and Mitotracker Red were excited by the 561 nm laser. Alexa 633 
conjugated dyes were excited by the 633 nm laser.  
For embryo imaging, optical slices were acquired at 1.1-μm thickness, and 
z stacks were oversampled at 0.467 μm. The 488 nm laser line was used to excite 
Dendra2 in the unconverted state. The mercury lamp was not used to avoid 
photoconversion. The same settings were used across all embryo-imaging 
experiments. Zen 2009 image analysis software was used to produce maximum 
intensity z-projections.  
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Membrane potential measurements 
Fluorescence of 5,5′,6,6′-tetrachloro-1,1′,3,3′ tetraethylbenzimidazolyl-
carbocyanine iodide (JC-1) was used to monitor mitochondrial membrane 
potential. Samples were loaded with a 6000 fold dilution (100 ng/ml) of JC-1 in 
media for 30 minutes at 37°C and then washed into fresh media. Samples were 
imaged live. The same acquisition settings were used across experiments. Images 
were analyzed in ImageJ. Briefly, individual cell borders were outlined, and mean 
fluorescence intensity was recorded for each channel using the Measurement tool. 
Data for at least 30 cells was averaged and the ratio of shRNA-treated:control was 
averaged across three independent replicates.   
 
PicoGreen nucleoid analysis 
Cells were loaded with a 500 fold dilution of PicoGreen and 250nM 
MitoTracker Red FM in media for 15 minutes at 37°C and then washed into fresh, 
pre-incubated media. Samples were imaged live. The same acquisition settings 
were used across experiments. Images were analyzed in ImageJ using the JACoP 
plugin Objects based method. Images were filtered using a threshold set by 
JACoP and individual objects segmented in each channel. The center of mass 
method was used to determine object colocalization with a minimum particle size 
of 0 and a maximum of 25600. The ratio of colocalized objects:total mitotracker 
objects was taken and averaged across at least ten separate frames.   
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qPCR 
qPCR of mtDNA was performed as described in (Chen et al., 2010) 
 
Retroviral expression constructs 
The Cox8-EGFP-mCherry retroviral vector (kindly provided by Dr. 
Prashant Mishra) consists of the Cox8 mitochondrial targeting sequence placed N-
terminal to an EGFP- mCherry fusion. The mito-targeted mTurquoise2 vector was 
pmTurquoise2-Mito (Addgene plasmid # 36208, Dorus Gadella, (Goedhart et al., 
2012)). To clone LC3 and p62-full length mTurquoise2 fusion proteins 
mTurquoise2 was amplified from this vector. Mouse P62 isoform 1 was amplified 
from pMXs-puro GFP-p62 (Addgene plasmid # 38277, Noboru Mizushima, 
(Itakura and Mizushima, 2011b)). mTurquoise2 and mCherry fusion proteins 
were cloned into the retroviral vector, pBABEpuro that was modified by addition 
of AgeI and BglII sites inserted between BamHI and EcoRI. 
mCherry/mTurquoise2 were inserted between AgeI and BglII, and p62 or LC3 
were cloned between EcoRI and SalI sites, resulting in a 12 amino acid linker 
between inserts. Truncation constructs of p62 were as follows: 
Full Length: aa1-443 
Nterm: aa1-233 
PB1: aa1-102 
ZZ: aa122-167 
Cterm: aa234-443 
LIR: aa321-349 
 
 156 
UBA: aa386-438 
All plasmids were verified by DNA sequence analysis. Stable cell lines 
were generated by retroviral infection followed by selection with 2 μg/μl 
puromycin. 
 
Analysis 
Images were cropped when appropriate and image contrast and brightness 
were globally adjusted in Photoshop (Adobe). Mitophagy quantifications were 
scored in triplicate with greater than 100 cells per experiment. 
Western densitometry analysis was done using ImageJ. Density of p62 
signal was normalized to density of VDAC1 signal and the average of two 
independent experiments was taken.  
For quantification of paternal mitochondria, maximum intensity z stacks 
were scored as having greater than 5, less than 5, or no distinct green puncta. 
Embryos from four females were pooled per experiment. For Nbr1 shRNA 
experiments two or more independent replicate experiments were averaged. For 
UBA expression experiments, a single experiment is shown.  
p values are the result of students two-tailed t test, except for embryo data, 
which are Chi-square analysis with two degrees of freedom.   
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FIGURE LEGENDS 
Table 3.1 Proteins with increased abundance in the mitochondria of MFN-
null cells. Summary of the most significantly increased proteins in mitochondria 
isolated from MFN-null MEFs. Ratios are MFN-null/wildtype.  
 
Figure 3.1 Increased P62 on mitochondria in the absence of mitofusins is 
necessary for maintaining mitochondrial membrane potential. (A) Western 
blot analysis of p62 expression in wildtype and MFN-null MEFs from whole cell 
lysate (WCL) or isolated mitochondria (mitochondria). VDAC1 is a loading 
control. Quantitation by densitometry plotted below, reported as p62/VDAC1 
normalized to wildtype. *, p <0.05. (B) Western blot analysis of p62 expression in 
mitochondria isolated from MFN-null MEFs untreated (control) or treated with 
two different p62 shRNAs (p62 sh1 and sh2). VDAC1 is a loading control. 
Quantitation by densitometry plotted below, reported as p62/VDAC1 normalized 
to control. *, p <0.05. (C) Co-localization of p62 with mitochondria. Wildtype or 
MFN-null MEFs were immunostained with anti p62 (green) and anti-HSP60 (red, 
mitochondrial marker). (D) JC-1 staining to measure relative ΔΨm in MFN-null 
MEFs with or without p62 shRNA. Cells were loaded with 100ng/mL JC-1 and J-
aggregates (ΔΨm dependent) or monomers (ΔΨm independent) were imaged as 
indicated. (E) Quantitation of JC-1 staining. Reported as mean fluorescence 
intensity per cell, averaged over three independent experiments. Note a significant 
reduction in J-aggregate accumulation (ΔΨm) in p62 shRNA cells with no change 
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in monomer uptake (mitochondrial mass). Error bars indicate SD. Scale bar, 10 
μm.  
 
Figure 3.2 P62 is required for degradation of a subset of defective 
mitochondria by mitophagy in MFN-null cells. (A) Co-localization of p62 with 
mtDNA and depolarized mitochondria. MFN-null MEFs stably expressing 
mTurquoise2-p62 (blue) were stained with MitoTracker Red (red, ΔΨm dependent 
mitochondrial marker) and immunostained with anti DNA (green). Arrows 
indicate mitochondria that co-localized with DNA but not with p62, arrowheads 
indicate mitochondria that co-localized with p62 but not with DNA. Note reduced 
MitoTracker intensity of mitochondria co-localized with p62. Scale bar, 10 μm. 
(B) Co-localization of mtDNA with mitochondria. MFN-null MEFs with or 
without p62 shRNA were stained with PicoGreen (green) and MitoTracker Red 
(red) and imaged. Quantitation on right is percent of mitochondria that co-localize 
with PicoGreen. Note equivalent mtDNA co-localization with or without p62 
shRNA. Scale bar, 10 μm. p value non-significant (ns) obtained from unpaired t 
test. Error bars indicate SD. (C) Mitochondrial copy number in MFN-null MEFs 
with and without p62 knockdown. P62 knockdown with two different shRNAs as 
indicated. To obtain the mtDNA level for a single DNA sample, quantitative PCR 
was performed in triplicate. p values non-significant (ns) obtained from unpaired t 
tests. Error bars indicate SD. (D) Mitophagy in MFN-null cells with and without 
p62 shRNA (sh2) or with p62 shRNA and exogenous full-length p62 (sh2 + p62-
Full). MEFs stably expressing Cox8-EGFP-mCherry mitophagy marker were 
 
 159 
imaged by fluorescence microscopy. P62 shRNA and/or full-length p62 were 
stably introduced by retroviral infection. Note that red-only puncta represent 
mitochondrial contents within acidic compartments. (E) Quantitation of percent of 
cells containing puncta from (D). Experiment performed in triplicate, greater than 
100 cells counted per experiment. ***, p <0.001. Scale bar, 10 μm. Error bars 
indicate SD. (F) Co-localization of LC3B with red-only puncta. MFN-null MEFs, 
with or without p62 shRNA, stably expressing cox8-EGFP-mCherry and 
mTurquoise2-LC3B were imaged by fluorescence microscopy. Note that 
mTurquoise2-LC3B puncta localize to mitochondrial puncta only in the absence 
of p62 shRNA. Scale bar, 10 μm.  
 
Figure 3.3 The PB1 and LIR domains but not the UBA of p62 are sufficient 
for its localization to mitochondria. (A) Co-localization of p62 with red-only 
mitochondria. MFN-null MEFs stably expressing Cox8-EGFP-mCherry and p62-
Turquoise were imaged. Arrows indicate yellow mitochondria (red + green) that 
do not co-localize with p62. Arrowheads indicate red-only mitochondria that co-
localize with p62. Scale bar, 10 μm. (B) MFN-null MEFs stably expressing cox8-
Turquoise2 (green, mitochondrial marker) and mCherry-p62Full (wildtype, 1-443 
amino acids), mCherry-p62Nterm (1-233 amino acids), mCherry-p62PB1 (1-102 
amino acids), mCherry-p62ZZ (122-167 amino acids), mCherry-p62Cterm (234-
443 amino acids), mCherry-p62LIR (321-349 amino acids), or mCherry-p62UBA 
(386-438 amino acids) (all in red) were imaged by confocal microscopy. Note that 
mitochondria co-localize predominantly with p62Full, p62Nterm, and p62PB1, 
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and to a lesser extent with p62Cterm and p62LIR, but not with p62UBA. Scale 
bar, 10 μm applies to (B) and (C). (C) Co-localization of p62PB1 with 
mitochondria in p62-KO MEFs. P62-KO MEFs stably expressing cox8-
Turquoise2 (green, mitochondrial marker), and mCherry-p62PB1 were grown in 
OXPHOS-inducing media to induce mitophagy. Note that p62PB1 co-localizes 
with mitochondrial puncta in the absence of endogenous p62.   
 
Figure 3.4 Ubiquitination of MFN-null mitochondria is dependent on p62. 
(A) Accumulation of polyubiquitinated proteins in mitochondria. Mitochondria 
from MFN-null MEFs with or without p62 shRNA were isolated by differential 
centrifugation. Mitochondrial lysates were analyzed by western blot for pan-
Ubiquitin. VDAC1 is a loading control. Note the reduced ubiquitin level in p62 
shRNA expressing cells. (B) Mitophagy in MFN-null cells with and without 
p62UBA. MEFs stably expressing Cox8-EGFP-mCherry mitophagy marker and 
mTurquoise2-p62UBA were imaged by fluorescence microscopy and percent of 
cells containing red-only puncta were counted. Note a slightly reduced percent of 
cells with puncta in the presence of p62-UBA. Experiment performed in triplicate, 
greater than 100 cells counted per experiment. ***, p <0.001. Error bars indicate 
SD. (C) Clearance of paternal mitochondria. Wildtype females were mated with 
male PhAM mice, and embryos were collected 12 hours after fertilization. 
Retrovirus encoding mCherry-p62UBA was injected in the perivitelline space. 
Control is un-injected. The mitochondrial Dendra2 signal was imaged live by 
fluorescence microscopy at 84 hours after fertilization. Images are representative 
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maximum intensity projections. Scale bar, 10 μm. (D) Quantitation of paternal 
mitochondrial elimination at 84 hours post-fertilization. Embryos were scored as 
having no paternal mitochondria (black bar), less than five clusters (white bar), or 
greater than five clusters (green bar).  
 
Figure 3.5 P62 homolog, Nbr1 is not required for mitophagy in MFN-null 
MEFs or embryos. (A) Mitophagy in MFN-null cells with and without NBR1 
shRNA. MEFs stably expressing Cox8-EGFP-mCherry mitophagy marker and 
NBR1 shRNA were imaged by fluorescence microscopy and percent of cells with 
red-only puncta were counted. Note that red-only puncta are observed at similar 
frequency in either case. Scale bar, 10 μm. Experiment performed in triplicate, 
greater than 100 cells counted per experiment. p value not significant (ns), 
student’s t-test, unpaired. Error bars indicate SD. (B) Clearance of paternal 
mitochondria. Wildtype females were mated with male PhAM mice, and embryos 
were collected 12 hours after fertilization. Lentivirus encoding non-targeting 
shRNA, p62 shRNA, NBR1 shRNA, or both p62 shRNA and NBR1 shRNA was 
injected in the perivitelline space. The mitochondrial Dendra2 signal was imaged 
live by fluorescence microscopy at 84 hours after fertilization. Images are 
representative maximum intensity projections. Scale bar, 10 μm. (C) Quantitation 
of paternal mitochondrial elimination at 84 hours post-fertilization. Embryos were 
scored as having no paternal mitochondria (black bar), less than five clusters 
(white bar), or greater than five clusters (green bar). The average of two 
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independent injection experiments is shown. p value not significant (ns), student’s 
t-test, unpaired. Error bars indicate SD. 
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Table 3.1 
 
Proteins with increased abundance in the mitochondria of MFN-null cells 
 
Protein Localization Biological Function SILAC ratioa Significanceb 
GATM Mitochondria Creatine synthesis 26.7 8.16E-12 
PON3 Unknown Metabolism 11.7 4.86E-07 
THBS1 ER UPR 7.2 1.34E-05 
CBR2 Mitochondria Metabolism 6.9 2.61E-05 
CA5B Mitochondria Metabolism 6.5 4.37E-05 
p62/SQSTM1 Cytosol Autophagy receptor 6.0 1.56E-03 
POLRMT Mitochondria mtDNA transcription 4.8 3.21E-04 
FAHD2 Mitochondria Metabolism 3.7 6.50E-04 
ECH1 Mitochondria Metabolism 3.5 2.36E-03 
aCombined SILAC ratio from two independent mass spectrometry experiments. The ratio 
represents the protein level in MFN-null mitochondria divided by the level in wild-type cells. 
bCorresponds to the significance calculated in MaxQuant. 
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Figure 3.1 
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Figure 3.2 
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Figure 3.3 
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Figure 3.4 
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Figure 3.5 
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C h a p t e r  4  
FUTURE DIRECTIONS 
MUL1 and the PINK1/PARKIN pathway 
We identified the E3 ligase, MUL1, as a protein that could partially 
compensate for loss of PARKIN in OXPHOS induced mitophagy and degradation 
of paternal mitochondria. The regulation of MUL1 in this context remains 
ambiguous. In contrast to PARKIN, which is a cytosolic protein recruited to 
mitochondria only under conditions of mitochondrial dysfunction, MUL1 is a 
resident mitochondrial protein. By what mechanism mitochondrial dysfunction 
might influence MUL1 mediated ubiquitination is unknown. Further mechanistic 
studies of MUL1 would help illuminate this issue. For instance, experiments to 
assess post-translational modifications on MUL1 under OXPHOS-induced 
mitophagy conditions would shed light on the changes that might take place to alter 
MUL1 function under those conditions. A direct test of a possible relationship 
between PINK1 and MUL1 would be assessment of MUL1 phosphorylation in a 
PINK1 wildtype or knockout background. Although MUL1 has two possible 
phosphorylation sites that are exposed to the cytoplasm, no such phosphorylation 
has been reported. 
Additionally, the interaction of MUL1 with the PINK1/PARKIN pathway is 
uncertain. In one model, MUL1 functions independently of PINK1 and PARKIN; 
in another, MUL1 acts downstream of PINK1, either directly or indirectly. Previous 
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work in Drosophila has shown that MUL1 acts in parallel to the PINK1/PARKIN 
pathway in ubiquitination of MFN. Overexpression of MUL1 suppresses 
dPink1/dParkin mutant phenotypes (Yun et al., 2014a). In this case, it was found 
that MUL1 is not a downstream target of PINK1. However, in our system PINK1 
knockout or PARKIN knockout with MUL1 knockdown impairs mitophagy 
whereas PARKIN knockout alone does not. Currently, PARKIN is the only E3 
ligase shown to act in a PINK1 dependent manner; however, the difference between 
PINK1 knockout and PARKIN knockout phenotypes that we observed might 
suggest that there are other essential mitophagy factors downstream of PINK1 other 
than PARKIN, or that PINK1 has another role in mitophagy beyond activating 
PARKIN. It is possible that MUL1 is such a factor. Therefore it would be 
informative to further analyze the relationship of MUL1 with PINK1 in mammalian 
cells. Ubiquitination of mitochondria is a quantitative readout that might facilitate 
epistasis analysis. Preliminary experiments with PINK-knockout MEFS in which 
MULAN has been knocked down suggest that there is no additive loss of 
ubiquitination of mitochondria, which might imply that it acts downstream of 
PINK1; however, this may be due to residual MUL1 protein. Construction of a 
MULAN/PINK1 double knockout might be more informative. Furthermore, so far 
we have analyzed ubiquitination of mitochondria in a linkage-independent fashion, 
using a pan-ubiquitin antibody. It might be important to assess the role of MULAN 
in facilitating specific polyubiquitin chain linkages, specifically K63-linked 
ubiquitin, since this is more reflective of autophagy-specific ubiquitination. It is 
also worth noting that the level of ubiquitination of mitochondria in PINK1 
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knockout cells is very low. Firstly, this may mean that the dynamic range of the 
ubiquitination assay in PINK1 knockout cells is not sufficient to detect a further 
decrease due to MUL1 knockout, in which case a more sensitive mass spectrometry 
based assay might be beneficial. Secondly, this may suggest that there are several 
downstream targets of PINK1, which are currently unknown. Consistent with this, a 
recent phosphoproteomic screen identified three RAB GTPases, Rab8A, 8B and 13 
that are phosphorylated at a conserved residue in response to PINK1 activation (Lai 
et al., 2015). How these proteins may function in mitophagy is unknown. Finally, 
the interesting way in which PINK1 is spared from degradation by depolarization of 
mitochondria may not be specific to PINK1. Perhaps other proteins are regulated in 
a similar manner. Identification of such proteins might help illuminate this issue as 
well. 
The work in Drosophila also suggested that MUL1 acts by ubiquitinating 
MFN. However, the changes that we observed in ubiquitination of mitochondria 
were quite profound, suggesting that perhaps MUL1 ubiquitinates more than just 
MFN. Also, the high level of mitophagy observed in MFN-null MEFs suggests that 
mitophagy can proceed in the absence of MFN. Further studies in two directions 
would help clarify this. Identification of other MUL1 substrates would be 
informative, particularly if these substrates are not also substrates of PARKIN. A 
number of mass spectrometry based approaches could be taken to answer this 
question. Comparison of ubiquitinated proteins in PARKIN knockout cells verses 
PARKIN/MUL1 double knockout cells is one possibility, but overexpression of 
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functional MUL1 or a ligase-dead MUL1 would be another. The dependence of 
such ubiquitination on PINK1 could also be assessed by this method.  
 
Tools for studying mitophagy: high throughput screening, and mitophagy 
mouse 
The PINK1/PARKIN-mediated mitophagy mechanism is an elegant 
cascade of events that links mitochondrial membrane potential to ubiquitination. It 
is unclear, however, if this is the only, or even the primary means by which 
mitochondrial dysfunction gets translated into mitophagy. Furthermore, there are 
significant differences in the players already identified in mitophagy triggered 
under different conditions, although some amount of mitochondrial stress is 
probably present in most of these cases. High throughput screening of shRNA 
libraries under various cellular stresses is made possible by the fluorescence-
quenching mitophagy assay that we have developed. Automated imaging of cells in 
a 96-well glass-bottom plate format coupled with image segmentation algorithms to 
distinguish red mitochondrial puncta could facilitate identification of the networks 
of proteins that are involved in each of these mitophagy contexts. Comparison of 
these networks could reveal common and unique mechanisms and help parse the 
currently scattered information we have about mitophagy pathways.   
Our embryo experiments suggest a potential physiological relevance for the 
mitophagy proteins that we identified in our cell-culture assay, and the involvement 
of NIX in erythrocyte differentiation makes it clearly relevant to normal 
physiology. However, one long-puzzling conundrum is that although mutations in 
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PINK1 and PARKIN are found in Parkinson’s disease patients, PINK1 and 
PARKIN knockout mouse models show surprisingly subtle phenotypes (Cookson, 
2012). This may be due to complementation with other proteins, and our results 
regarding MUL1 support this idea, but it also suggests that there is much we do not 
understand about mitophagy in the whole organism context. The fluorescence-
quenching assay that we have shown can be used as tool to monitor mitophagy in 
the mouse. Indeed, Sun et al., have created a transgenic mouse expressing a similar 
matrix-targeted pH dependent construct utilizing the fluorescent reporter Keima 
(mt-Keima) (Sun et al., 2015). This mouse can be used to address the physiological 
relevance of the mitophagy players so far identified, and the potential tissue 
specificity of each.  
 
Persistence of paternal mitochondria in mice 
One puzzling question regarding the maternal mode of mtDNA inheritance 
is a teleological one. Why doesn’t paternal mtDNA persist? Is it because 
heteroplasmy in general is detrimental to the organism (Sharpley et al., 2012), or is 
it a selfish act on the part of the female that has no phenotypic outcome (Agnati et 
al., 2009)? The principles of natural selection would suggest that there must be 
some deleterious effect of paternal mtDNA persistence. Some evidence exists 
suggesting that heteroplasmy causes altered behavior, respiratory exchange ratio, 
and cognitive impairment in mice (Sharpley et al., 2012), and some sporadic cases 
of Parkinson’s disease in humans show increased heteroplasmy, although it is not 
specifically localized to the substantia nigra so a case for a causal relationship to the 
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disease phenotype is difficult to envision (Schnopp et al., 1996). An alternate model 
is based on the observation that mtDNA can exhibit so-called “selfish selection” 
which favors mtDNA haplotypes with a replication advantage despite any 
deleterious effect on cell fitness (Aanen et al., 2014; Ma et al., 2014). Matrilinear 
inheritance of mtDNA restricts the opportunities for selfish mtDNA mutations to 
spread. The phenotypic effect of persistent paternal mitochondria, however, has 
been difficult to test in the absence of specific genes involved in the process.  
We have shown that loss of mitophagy proteins in mouse embryos can 
inhibit or delay degradation of paternal mitochondria. We do not know, however, 
whether the paternal mitochondria that we detect in pre-implantation embryos with 
mitophagy protein knockdown would persist in an adult animal, or whether another 
mechanism exists that would later degrade these mitochondria. If the paternal 
mitochondria were maintained in adult animals, potential phenotypes in these 
animals could be investigated. 
One way to answer this question is by PCR of mtDNA from mouse pups 
born of a cross between parents with differing mtDNA haplotypes. A previous 
paper demonstrated the feasibility of this approach (Luo et al., 2013); however, they 
found that mtDNA from the male parent could be detected stochastically at a low 
frequency in wildtype animals, suggesting that perhaps degradation mechanisms are 
not normally completely efficient. Nonetheless, a quantitative version of this 
technique might be able to determine whether mtDNA from the male parent is more 
often detected in offspring that are mitophagy protein mutants. Of the proteins we 
identified as being important in mitophagy of paternal mitochondria, knockout mice 
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of PINK1 and p62 have been made and are viable (Gautier et al., 2008; Harada et 
al., 2013). FIS1 knockout males do not produce viable sperm, and since this protein 
is expected to be important on the paternal mitochondria, rather than in the egg 
cytoplasm, it is difficult to test the involvement of FIS1 by this method. To our 
knowledge a TBC1D15 knockout mouse does not exist. Relatively rapid generation 
of genetically modified mice is now possible using the CRISPR/Cas-mediated 
genome engineering method (Yang et al., 2014), and this could be employed to 
generate a TBC1D15 knockout. One challenge with this approach is that the 
offspring of a homozygous mutant female and wildtype male are heterozygotes, 
which would only facilitate testing the function of these proteins prior to the 
maternal-zygotic transition. Furthermore, germ cells generally contain protein 
contributed by the parental support cells, which could contaminate such an 
experiment. A better experiment would involve a cross wherein both parents are 
mutants, which would first require generation of a new mutant line with an alternate 
mtDNA haplotype.  
In our embryo experiments, we introduced virus by microinjection of 
fertilized oocytes, which is a laborious technique, limiting the number of proteins 
that can be screened. Another interesting possibility that would enable higher 
throughput screening of shRNAs is incubation of denuded embryos (zona 
pellucidae removed) in media containing a virus. This method was shown to 
generate transgenic mice at a similar frequency to embryo microinjection (Lois et 
al., 2002). By this method, embryos could be collected from fertilized females, 
denuded, and incubated with virus in a multiplexed format, wherein they could be 
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imaged. The high variability amongst embryos would necessitate a relatively large 
number of embryos to be collected, but this method could nonetheless yield rapid 
results and would help control for variability in the multiplicity of infection due to 
differences in the amount of virus injected in each embryo.  
 
The role of p62 on mitochondria 
We have shown here that loss of mitochondrial fusion results in an increase 
in mitophagy, which is consistent with previous studies suggesting a protective role 
for fusion, which facilitates mixing of mitochondrial contents, allowing 
complementation of function (Sato et al., 2006). As well as with studies showing 
that overexpression of FIS1 drives mitophagy (Alirol et al., 2006) and that fission 
helps segregate dysfunctional mitochondria which are prevented from fusing with 
the functional pool (Twig et al., 2008). The latter study suggests that functional 
status, as evinced by ΔΨm determines mitophagy rather than fragmentation per se. 
We have shown a critical role for p62 in mitophagy in MFN-null cells. It is not 
clear, however, what dictates p62 translocation to mitochondria, since we find that 
the UBA domain of p62 is dispensable for this localization. Interestingly, previous 
studies have implicated p62 in mitochondrial morphology, protein import, and 
maintenance of mtDNA (Seibenhener et al., 2013a). Could p62 be a direct sensor of 
mitochondrial function rather than simply an adaptor to the autophagosome? To 
address this question, further studies of the localization of p62 to mitochondria are 
needed. In particular, to which sub-compartment of mitochondria p62 localizes will 
be informative. It is likely to be associated with the OMM, since it does not contain 
 
 185 
a mitochondrial localization sequence. Furthermore, identification of p62 binding 
partners on the mitochondria would be informative in understanding the 
mechanisms by which it senses and/or influences mitochondrial stress. A 
preliminary co-immunoprecipitation experiment suggests that there may be an 
association between p62 and the complex that forms the mitochondrial OMM-
cristae junctions, but this remains to be validated. The PB1 domain of p62 appears 
to be a key determinant of p62 localization to mitochondria. It would be useful to 
learn which proteins on mitochondria specifically bind to this domain, and how 
these proteins are altered under conditions of stress. 
Another interesting facet of the ΔΨm mediated mitophagy model is that 
mitochondria are highly dynamic. As illustrated by the Crabtree effect in cultured 
cells (Diaz-Ruiz et al., 2011), mitochondria can readily increase and decrease 
OXPHOS activity. It would seem wasteful for the attendant changes in ΔΨm to 
invariably lead to mitophagy. It stands to reason, therefore, that there might be 
some threshold ΔΨm below which loss of fusion and mitophagy occurs. A 
quantitative analysis of the correlation between ΔΨm and mitophagy that could 
reveal such a threshold, or perhaps a linear relationship might be enlightening in 
this regard.  
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